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ABSTRACT 
ANAND DORAISWAMY: Novel CAD/CAM Rapid Prototyping of Next-generation 
Biomedical Devices 
(Under the direction of Roger J. Narayan) 
 
An aging population with growing healthcare needs demands multifaceted tools 
for diagnosis and treatment of health conditions. In the near-future, drug-administration 
devices, implantable devices/sensors, enhanced prosthesis, artificial and unique 
functional tissue constructs will become increasingly significant. Conventional 
technologies for mass-produced implants do not adequately take individual patient 
anatomy into consideration. Development of novel CAD/CAM rapid prototyping 
techniques may significantly accelerate progress of these devices for next-generation 
patient-care.  
In this dissertation, several novel rapid prototyping techniques have been 
introduced for next-generation biomedical applications. Two-photon polymerization was 
developed to microfabricate scaffolds for tissue engineering, microneedles for drug-
delivery and ossicular replacement prostheses. Various photoplymers were evaluated for 
feasibility, mechanical properties, cytotoxicity, and surface properties. Laser direct write 
using MDW was utilized for developing microstructures of bioceramics such as 
hydroxyapatite, and viable mammalian osteosarcoma cells. CAD/CAM laser 
micromachining (CLM) was developed to engineer biointerfaces as surface recognition
 
iii 
regions for differential adherence of cells and growth into tissue-like networks. CLM was 
also developed for engineering multi-cellular vascular networks. Cytotoxic evaluations 
and growth studies demonstrated VEGF-induced proliferation of HAAE-1 human aortic 
endothelial cells with inhibition of HA-VSMC human aortic smooth muscle cells. 
Finally, piiezoelectric inkjet printing was developed for controlled administration of 
natural and synthetic adhesives to overcome several problems associated with 
conventional tissue bonding materials, and greatly improve wound repair in next 
generation eye repair, fracture fixation, organ fixation, wound closure, tissue engineering, 
and drug delivery devices.  
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CHAPTER 1 
INTRODUCTION 
 
This dissertation establishes novel CAD/CAM rapid prototyping techniques for 
processing advanced biomaterials for a variety of biomedical applications. The first chapter 
highlights the various aspects involved in understanding the increasing demands for 
development of novel technologies for biomedical applications.  
 
1.1 Rapid Prototyping (RP) 
Rapid prototyping (RP) is a material processing technology originally developed 
approximately thirty years ago for the preparation of machine tool prototypes.1 It is a process 
planning technology that offers rapid production with design verification, automation, 
manufacturability, reliability, iterations, visualization, and allowing just in time manufacture. 
In conventional rapid prototyping, three-dimensional structures are created by selectively 
joining materials in an additive manner, or subtraction/removal of materials from stock 
(machining). These technologies include processing solids, liquids, or powders. 
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Solid-based rapid prototyping techniques involve the cutting and joining or 
fusing/solidifying or melting of extruded material (in the form of wire, roll, laminates, and 
pellets).2 Fused deposition modeling (FDM) is a widely used solid-based rapid prototyping 
technique where the material is melted and extruded from the head (Figure 1) into thin 
filaments of liquid, pastes, melts, or reactive materials on a mobile platform, which can 
operate along X-, Y-, and Z- planes. The filaments fuse together upon cooling with the 
previously deposited layer. Advantages of the FDM process includes rapid building of bottle-
like and hollow parts, costs, non-toxicity, and easy handling. Disadvantages of fused 
deposition modeling include high operating temperatures that preclude patterning of many 
biological materials due to thermal denaturation.3 In addition, materials prepared using this 
process exhibit very high porosities and poor mechanical properties. Accuracy of the build is 
very low and it is difficult to build parts with complicated details. The FDM technology is 
marketed exclusively by Stratasys Inc.4 and often used to process polycarbonate materials, 
polyphenylsulfones and waxes.  
 Liquid-based techniques involve selective solidification of material in the liquid 
phase. Stereolithography (SLA) is a liquid-based rapid prototyping technique where a 
photocurable resin is selectively solidified upon exposure to ultraviolet laser radiation. The 
laser polymerizes the liquid resin layer to generate a layer of solidified material. Subsequent 
layers are selectively cured and this layer-by-layer buildup process is repeated until the 
desired three-dimensional (3D) structure is obtained. The structure is then removed from the 
liquid reservoir, baked, and cleaned.  In this technique, the interplay between encoder 
resolution, table step height, and laser spot size often determine the resolution of structures 
fabricated. Advantages of this process include good surface finish, easy curing, and relatively 
 
3 
high resolutions of end product. Compensation for shrinkage and changes in polymer 
properties are some issues associated with the process. High operating temperatures and laser 
power/wavelengths that damage biological components reduce applicability of this process.6-
7 In addition, breakdown products, diluents, and dispersants used in stereolithography may 
not be suitable for many medical and biological applications.  
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Figure 1: Schematic of the fused deposition modeling (FDM) process.5 
 
 
 
Figure 2: Schematic of the stereolithography (SLA) process.8 
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Powder-based rapid prototyping techniques such as selective laser sintering (SLS) 
involve selective melting of powders or granules in a powder bed using a high power laser. 
In SLS prior to laser exposure, the powder is annealed to a temperature close to its transition 
melting point, such that only a small increase in temperature is required to cause localized 
melting. A three-dimensional object is formed by moving the height-adjustable table 
containing the powder bed after processing of each layer (Figure 3). This technique has been 
utilized to fabricate complex porous ceramic matrices suitable for implantation in a bone 
defect.9 Many other materials, including nylon, polystyrene, and titanium, may also be 
processed using this technique. The technique has the capability to process 3D structures 
with complex features, including overhangs and undercuts. However, materials processed 
using selective laser sintering generally exhibit high porosity and surface roughness, which 
may preclude its use in many medical applications. Although, process parameters such as the 
laser spot size, laser energy, scan speed, and bed temperature can be controlled to determine 
the resulting porosity and surface roughness of the final 3D structure. 
A comparative summary of standard rapid prototyping methods for biomedical 
applications have been previously reported by Boland et al.11 Conventional rapid prototyping 
techniques have serious limitations towards developing and processing materials for growing 
needs in the biomedical field. High temperature of processing, poor accuracy and resolutions 
and other limitations preclude the use of conventional approaches for microfabrication of 
biomaterials. The main goal of this dissertation was to develop novel CAD/CAM processing 
techniques for microfabrication of biomaterials for various medical applications. In current 
rapidly growing biomedical fields, efficient and controlled processing of organic and 
inorganic biological materials can be seen as an imminent requirement.  
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Figure 3: Schematic of the selective laser sintering (SLS) process.10 
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1.2 Laser Based Technology 
Free form fabrication of microstructured medical devices presents great growth 
potential in a growing medical device market. In developing laser based techniques for rapid 
prototyping, it is critical to establish the structure-property correlation during laser interaction 
with material. As shown in Figure 4, various possible events (release of photons, charged 
particles, vapor, absorption, spallation, etc.) occur during laser interaction with a solid.  
Absorption of photons causes various thermal and athermal reactions in materials. In 
photothermal interactions, the incident light energy is absorbed and transformed to heat 
energy. The absorption occurs according to the exponential absorption law: Light intensity at 
depth x, I(x) = Ioe-ax; where ‘a’ is the absorption coefficient of material. Athermal 
interactions include photoelectrical, photochemical, and photophysical effects.13 
Photoelectrical effects occur with the emission of electrons and ionized species with 
sufficient laser energy. Laser lights can also be used to modify the electric fields in the 
interaction zone. Photochemical effects cause alteration of chemical bonds by absorption of 
photons. Bonds can be formed (photochemical curing) or broken (micromachining and 
photochemical disruption).   Photophysical effects involve the removal of material by direct 
cleaving of molecular bonds at high laser energy. Processes such as photoablation, plasma-
induced ablation, and photodisruption are photophysical effects, where material is removed 
by breaking molecular bonds, by the formation of ionizing species (plasma), and by 
mechanical forces, respectively.14 
Laser-induced effects such as photothermal ablation, photovaporization, 
photomelting, are often used in biomedical applications such as tissue ablation, atherectomy, 
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disposable medical devices, stents, catheter drilling, retinal attachment, engraving and 
texturing.12-13 Lasers have found many medical uses due to their ability to direct high energy 
radiation of a single wavelength onto a focused location. Use of lasers to process 
biomaterials may transfer directly into clinical setting. In developing laser-based rapid 
prototyping tools for biomedical applications, it is vital to understand the laser interaction 
with biomaterials. 
 
1.3 Two-photon Polymerization (2PP) 
Two photon polymerization (2PP) is an additive process that involves both temporal 
and spatial overlap of photons to induce chemical reactions between starter molecules and 
monomers within a transparent matrix.15 Near simultaneous absorption of two photons 
creates a so-called virtual state for several femtoseconds. This electronic excitation is 
analogous to electronic excitation by a single photon with a much higher energy. When the 
two photons are of different wavelengths, the process is referred to as non-degenerate two 
photon absorption.16 When the two photons are of identical wavelengths, the process is 
referred to as degenerate two photon absorption. The two photon absorption process exhibits 
a non-linear (quadratic) dependence on the incident intensity. Negligible absorption occurs 
except in the immediate vicinity of the focal volume of the light beam. Hence, high 
resolution polymerization is achievable using appropriate optics. Photonic crystals, micro-
rotors, microcapsules, micro-pillars, mechanical devices (tubes, oscillators, gear wheels, 
chains) are some of the many structures that have been fabricated by this technique.17-19 
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Amorphous organic-inorganic hybrid materials (organically modified ceramics, or 
Ormocer®) and other photopolymers can be polymerized using this process with the use of 
appropriate initiator species. Ormocer® materials are prepared by sol-gel processes from 
liquid precursors, and contain organically modified silicon alkoxides, metal alkoxides, and 
organic monomers. Strong covalent bonds form between the ceramic and polymer moieties 
during the two photon induced polymerization reactions. The inorganic components (e.g., 
alkoxysilane precursors) crosslink and form inorganic silicon-oxygen-silicon networks 
through condensation of organically modified silicon alkoxides and controlled hydrolysis. 
The organic components (e.g., methacrylate groups) crosslink through light-, thermal-, or 
redox-initiated processes.21 The crosslinking of both organic and inorganic components 
creates a three dimensional network, which prevents separation of the material into separate 
phases and provides Ormocer® material with exceptional chemical and thermal stability. For 
example, Ormocer® materials exhibit duroplastic behavior on heating; they remain stable to 
350 °C in an oxygen atmosphere and 415 °C in a nitrogen atmosphere.22 
Development of 2PP as a novel rapid prototyping technology is presented in Chapter 
three. Applications in three-dimensional microstructured medical devices, scaffolds for tissue 
engineering, microneedles for drug delivery, and ossicular implants are discussed.  
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Figure 4: Schematic of possible events during laser interaction with a solid material.12 
 
 
 
 
Figure 5: Schematic of the two-photon polymerization system.18 
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1.4 MAPLE Direct Write (MDW) 
Two-dimensional patterning of a single cell-type has been demonstrated previously 
by various surface recognition techniques. In a biomimetic approach Garcia et al.23 
demonstrate that the cell adhesion, proliferation, and differentiation can be controlled by 
functionalizing the surface using RGD peptides. In another approach, laminar flow of the 
media in capillary systems has been used to create simple patterns of different types of “cells 
and proteins” within the same substrate.24 Laborious steps are used to create elastomeric 
stencils using photoresists that are then used as masks to pattern cells and proteins.25 Soft 
photolithographic methods such as microcontact printing, which involve the fabrication of 
stamps using masking techniques, have been demonstrated to create cell and protein 
patterns.26, 27 Rapid patterning techniques were proposed by using dielectrophoretic force to 
transfer cells from the electrode to a glass substrate, however with relatively low resolutions 
and accuracy.28 
Matrix-assisted pulsed laser evaporation direct-write (MDW) was originally 
developed to satisfy the need for conformal and mesoscopic passive electronic components.29 
As in a typewriter ribbon, the material to be transferred is solvated and evenly coated on the 
ribbon surface. The incident light is absorbed by the solvent, and the solute material is driven 
forward to a receiving substrate. The resolution and pattern is controlled by distance between 
the ribbon and substrate, laser energy-density, spot-size, and translation speed of the stage. 
This process (Figure 6) has recently been extended to soft and biological materials including 
a variety of polymers, biomolecules, and viable cells. Using this process various lines of 
viable cells have been generated into mesoscopic patterns onto a variety of receiving 
substrates.30, 31 Such a technique may allow integration of cell into the matrix while the 
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construct is being created. The development of MDW as a novel rapid prototyping tool for 
regenerative medicine is presented in detail in Chapter three. 
 
1.5 CAD/CAM Laser Micromachining (CLM) 
Laser micromachining of materials have been previously employed as a rapid 
prototyping technique for developing microfluidic devices with channel features of ~ 10 μm 
with relative ease.32 Micromachining of various materials including poly(dimethylsiloxane), 
GaN, SiC, fused silica, quartz, sapphire, have been studied for developing microchips, 
intracortical probes33, microstructure parts34, hybrid processing35, and surface 
modifications36.  Extending MDW technology to higher laser power allows CAD/CAM laser 
micromachining capabilities using previous setup (Figure 6). The micropositioning system is 
integrated with the CAD model (3D geometry) and laser process parameters (laser energy 
density, laser spot-size, laser pulse frequency, remote trigger) to allow efficient processing 
capabilities. Laser interaction with a material is unique and thus the processing parameters 
and integration needs to be developed for each new material.  
One possible application for laser micromachining of biomaterials is in tissue 
engineering. 2D silicon micromachining (by etching) has been previously studied for 
developing vascular channels.37 CAD/CAM laser micromachining of biomaterials may allow 
better control for a 3D geometry in the micron scale. CLM may allow development of 
differential adherent structures with programmed dimensions and required functionality. The 
development of CAD/CAM laser micromachining (CLM) for tissue engineering applications 
is presented in detail in Chapter three. 
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Figure 6: Experimental setup and schematic of the MDW and CLM process.30 
 
 
 
Figure 7: Schematic of the piezoelectric print-head.45 
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1.6 Piezoelectric Ink-jet Technology (PIT) 
One possible application for rapid prototyping technology is microscale processing of 
biomaterials. CAD/CAM rapid prototyping techniques such as ink jet printing may allow for 
high-throughput production of patterned multiplexed biological materials without the use of 
masks, stamps, ribbons, or other expensive processing equipment.38, 39 The general principle 
of operation involves the creation of a rapidly moving stream of fluid that passes through a 
small nozzle. Ink-jet technology was initially developed as a thermal non-contact printing 
process, where drops were created by thermal stimulus.40, 41 In thermal printing, a resistive 
element is used to heat the fluid creating a bubble that forces the ink out of the nozzle. A 
similar process has been utilized for printing proteins and various living cells.42-44 However, 
the thermal stimulus does not entirely preclude damage to biological materials.  
 In athermal ink-jet printing technology, syringe-solenoid and piezoelectric systems 
have been previously developed.46 In a solenoid system, a syringe pump is used with a 
microsolenoid actuator to create controlled fluid flow across an orifice. However, high 
internal pressures can result in damage to the print-head. In a piezoelectric ink-jet system 
(Figure 7), piezoelectric crystals are used to create mechanical vibrations to control fluid 
flow via the nozzle by the application of external voltage. Piezoelectric printers are 
categorized based on the deformation mode such as squeeze, bend, push and shear modes in 
the piezoelectric crystal.47 Ink-jet printers can dispense a wide range of volumes from 
picoliters to microliters with a firing frequency between 5 – 12 kHz and resolutions greater in 
tens of micrometers. Resolution of the printed features are dependent on various factors 
including fluid viscosity, surface tension, fluid-mass velocity, nozzle size, droplet size, and 
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lateral resolution of the printer head. The development of piezoelectric ink-jet technology as 
a rapid prototyping tool for biomedical applications is presented in Chapter three.  
In a rapidly growing field of biomedical engineering, there is a rising need for novel 
CAD/CAM rapid prototyping technology. The following sections ahead describe the focus 
areas in biomedical engineering where novel RP techniques may provide vital, innovative, 
and enhanced solutions.  
 
1.7 Microneedles for Next-generation Drug Administration 
Microneedles provide a unique approach for transdermal drug delivery of DNA- and 
protein-based pharmacologic agents.48. Many of these novel agents cannot be administered 
orally or transdermally, because they may be metabolized by the liver, intestine, kidneys, or 
lungs before reaching systemic circulation. These agents may be administered intravenously 
to avoid diffusional/enzymatic barriers and provide complete and instantaneous absorption. 
Intravenous administration of pharmacologic agents usually involves the use of hypodermic 
needles, which provide injection directly into blood vessels, muscles, or subdermal fat.49 
These conventional needles are limited by traditional manufacturing processes to outer 
diameters of ~ 300 μm and wall thicknesses of 75 μm. In addition, use of hypodermic 
needles involves pain, trauma at the injection site, medical expertise to administer the 
injection, and difficulty in providing sustained/controlled delivery of the agent.  
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One emerging option for delivery of pharmacologic agents involves the use of 
microneedles. The use of microneedles for drug delivery was proposed in the 1970s; 
however, these devices have been fabricated using novel microfabrication tools only within 
the past decade.50 These devices, which can take the shape of lancets, thorns, or miniaturized 
hypodermic needles, contain at least one dimension that is less than 500 μm in length. By 
reducing the needle dimensions, pain to the patient and damage at the injection site may be 
reduced. In addition, administration of pharmacologic agents via microneedles requires no 
specialized medical training; the microneedles may be utilized in a similar manner to 
conventional transdermal patches. The amount and rate of drug delivery can be precisely 
controlled. For example, hollow microneedles may allow diffusion- or pressure-driven 
transport of pharmacologic agents through the needle bore to be adjusted over an extended 
period of time. By reversing the valve direction, pumps used for drug delivery through the 
microneedle can also be used for fluid extraction.51, 52 
Microneedles must meet several requirements in order to be effective for drug 
delivery. Microneedles for drug delivery must penetrate the outermost 15 μm of epidermis, 
known as the stratum corneum layer, which contains keratinized dead cells and serves as the 
highest barrier against drug transport through the skin.53 Microneedle shafts must be greater 
than 100 μm in length and 300–400 μm in length, since mammalian stratum corneum is 
flexible and variable in thickness. In addition, microneedles with high aspect ratios and small 
radii of curvature require lower forces for skin penetration.54 The microneedles must also not 
fracture during skin penetration. The ratio between microneedle fracture and skin insertion 
force is highest for needles exhibiting large wall angles, large wall thicknesses, and small tip 
radii. Finally, arrays of microneedles provide injection or extraction over a wider area and at 
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higher rates than solitary needles. Having several needles provides redundancy in case 
individual needles are obstructed or fractured during insertion.55 In addition, arrays of 
needles possess a greater possibility of directly reaching dermal blood vessels for extraction. 
Microneedle arrays are also less prone to fracture if exposed to shear force, because the shear 
force is distributed over a wider area.56 
Several investigators have demonstrated individual microneedles and microneedle 
arrays using conventional microelectronics fabrication technologies, including chemical 
isotropic etching, injection molding, reactive ion etching, surface micromachining, bulk 
micromachining, polysilicon micromolding, and lithography–electroforming–replication 
(LIGA) techniques.57-61 These techniques have inherent limitations in terms of fabricating 
array structures with high microneedle densities or large microneedle wall thicknesses. As a 
result, conventional microneedle devices have yet to find widespread clinical use. 
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Figure 8: Scanning electron micrograph of an array of polymeric microneedles.11 
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1.8 Ossicular Replacement Prosthesis 
In human ear, the malleus, incus, and stapes bones allow transmission of sounds from 
the tympanic membrane to the inner ear. Diseases of the middle ear may cause discontinuity 
or fixation of the ossicles, which results in conductive hearing loss. For example, ossicular 
damage may result from chronic otitis media, cholesteatoma, trauma, neoplasia, or congenital 
malformation.62, 63 Fixation of the ossicular chain may result from tympanosclerosis, from 
malleus head ankylosis, or from otosclerosis. Over the last 40 years, otologists have sought 
alternatives in materials and designs for ossicular reconstruction prostheses to provide 
favorable sound transmission and tissue compatibility.64-66 Middle ear implants must also be 
able to perform microscale movements between the tympanic membrane and the inner ear. 
Traditional methods for restoring sound conduction in the middle ear involve the use of the 
remaining ossicles.67 A commonly used material in ossicular replacement procedures is the 
patient’s own incus bone. However, autograft materials are not always available in cases of 
chronic middle ear disease. Additional concerns include high operative times and loss of 
structural rigidity.  
Synthetic materials such as polyethylene, polytetrafluoroethylene (PTFE), and 
Proplast (PTFE–carbon composite) pistons have been employed in middle ear 
reconstruction.68 These materials have shown extrusion, migration, and cytotoxicity. Metals 
including titanium and gold have also been attempted for prosthesis replacement.69-74 
Titanium prostheses have demonstrated cytocompatibility, sound conduction, and mechanical 
properties. However, recent studies have shown that cartilage grafts are required to cover the 
head plate of the prosthesis to prevent prosthesis extrusion through the tympanic membrane. 
Bioactive materials (such as Bioglass, Ceravital, hydroxyapatite) have also been employed 
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due to low extrusion.75-80 However, concerns remain with brittleness, difficulty in shaping the 
prostheses, and mechanical instability.  
Novel materials and prostheses that provide improved sound transmission for longer 
periods of time are demanded by patients and otologic surgeons. These materials must 
demonstrate appropriate stiffness, cytocompatibility, sound conduction, and ease of 
handling.81, 82 Conventional technologies for mass-produced implants do not adequately take 
individual patient anatomy into consideration. Development of patient-specific implants by 
novel rapid prototyping technology may allow rapid iterations with better compatibility and 
lowered costs of development.  
 
1.9 Tissue Engineering and Regenerative Medicine 
Tissue substitutes for use in repairing acute injury, chronic disease, or congenital 
defects may be created in different ways.83, 84 In autograft tissue transplantation, tissue is 
relocated from one site to another within the same person. The use of autograft tissue is 
associated with many problems, including limited availability of tissue. Additionally, surgery 
at the donor tissue site can cause infection, inflammation, chronic pain, and the need for 
additional surgery. In allograft tissue transplantation, tissue is transferred from one person to 
another. Twenty five tissues and organs, including cartilage, cornea, heart, kidney, liver, 
lung, and pancreas, have been transplanted between different people. However, allograft 
transplantation is also fraught with many problems, with limited availability being the 
primary issue. There are currently 80,000 people on organ waiting lists in the United States, 
and over 10,000 people have died over the last five years waiting for organs.85 In addition, 
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the recipient’s immune system generates acute vascular rejection and chronic rejection 
processes that break down transplanted allograft tissue in hours, days, weeks, months, and 
years after implantation.86 The immunosuppressive therapy used to counteract the rejection 
process may itself lead to tumor formation. There is also the risk of infection transmission 
from allograft organ donor to allograft organ recipient. For example, it has been estimated 
that the possibility of HIV transmission with allograft bone transplant is one case in 1.6 
million.87 One case of hepatitis B transmission and three cases of hepatitis C transmission 
have been correlated with allograft transplantation.88 
The continuing limitations of natural graft therapies and the growing demand for 
tissue substitutes have led to the growth of a field known as tissue engineering.89 Tissue 
engineering or regenerative medicine may be defined as the use of living cells that are 
manipulated genetically or through their environment with bioresorbable materials as matrix 
that help guide development to biologically functional tissue substitutes for implantation into 
the body. Construct technology for tissue engineering is generally approached in either a cell-
seeded method using various types of bioresorbable matrix materials or a cell-mediated self-
assembly technology.90 In the first approach, the cell-seeded structures are often placed in 
bioreactors that provide nutrients and allow cells to multiply within the scaffold, and 
implanted in the body so that it will resume normal function. Unfortunately, three-
dimensional scaffold seeding is very difficult because many cells do not exhibit sufficient 
multiplication within in vitro bioreactors.  
Conventional scaffold technology does not allow penetration of cells into the 3D 
matrix. Solvent-based direct writing techniques for making organic or cellular films (e.g., ink 
jetting, Langmuir-Blodgett dip coating, and pin arraying) have recently been used to fabricate 
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2D and 3D cell-seeded scaffolds for use in tissue engineering. Langmuir-Blodgett (L-B) 
coatings are capable of creating multilayered cell-seeded films; however, increasing L-B film 
thickness requires repeating the coating procedure for each additional layer. L-B coatings are 
also limited in the choice of materials used to create these films. Furthermore, the solvent 
containing the material of interest may dissolve any underlying layers. These techniques also 
have limitations in resolution, scale up, speed, and quality. 
Selection of bio materials is a critical step in developing 3D tissue constructs. 
Traditional scaffold materials include natural (Collagen, extraceullar matrix proteins) and 
synthetic degradable organic polymers such as PCL (poly-caprolactone), PLA (poly-lactic 
acid), PGA (poly-glycolic acid), hydrogels and other non-biodegradable materials. Inorganic 
materials such as bioceramics (hydroxyapatite) are known to be osteoconductive  and offer 
excellent structural integrity with varying bioresorbability, both of which are vital for any 
tissue construct.91, 92  Some important considerations of scaffold biomaterials include 
mechanical properties, structural integrity, ease-of handling/processing, cytotoxicity, shelf-
life, and bioresorbability.93 
In developing novel tissue engineering techniques, it may be significant to have 
control over cellular penetration, neo-vasculature, concentration gradients of growth factors 
and various cells, and integration of microstructures/biomaterials. These factors combined 
with a CAD/CAM feature for the macrostructure may be imperative to provide sufficient 
leverage and interest over conventional technologies for developing improved tissue 
constructs.  
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Table 1. List of key factors when considering a novel tissue engineering approach.89-94  
 
 
• Extent of distribution and penetration (3D) of cell into 
scaffold matrix material.  
• Conventional methods follow a cell-seeded self-assembly 
and may not allow control over cell-penetration. 
 
• Vasculature to nourish the cells in the interior of the scaffold.  
• Variable porosity in the scaffold-matrix material may allow 
neovascularization. 
 
 
• Concentration gradients of growth factors, e.g. VEGF may 
be required to facilitate appropriate cellular chemotactic 
responses and functional differentiations. 
• Concentration gradients of growth factors may also optimize 
cell-locomotion and speed-up angiogenesis.  
 
 
• Incorporation of spatial control over cellular heterogeneity.  
• Cellular heterogeneity may vary depending on the target 
tissue (may include endothelial, epithelial, muscle cells, 
nerve cells, cartilage, tendon, bone cells, etc.).  
 
 
• Integration of different (organic/inorganic) materials into 
one scaffold. 
• Control over material microstructure may allow 
mechanical and functional versatility within the construct.  
*Images incorporated from.94 
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Tissue engineering of the cardiovascular system may be one of the most challenging 
areas in regenerative medicine. In the past few years, several efforts in engineering blood 
vessel substitutes have been made.95 Autologous endothelial cells derived from veins have 
been used on scaffolds derived from polycaprolactone-polylactic acid (PCL-PLA) and 
polyglycolic acid (PGA) copolymers and implanted in patients with good short-term 
results.96 Smooth muscle cells and endothelial cells derived from veins, arteries, omenal fat, 
and subcutaneous fat have been seeded (monolayer) on tubular polyglycolic acid (PGA) 
scaffold to develop pulmonary artery conduits.97 Vascular networks have also been 
developed under flow conditions by seeding monolayer bovine vascular cells on tubular 
polymeric grafts.98, 99 De-cellularized biologic ECM from human fibroblasts have also been 
employed as scaffold material for development of vascular networks.100  
A schematic of the human artery is shown in Figure 9. The various concentric layers 
from the center include tunica intima, elastin, tunica media, tunica externa, and serosa. 
Tunica intima contains a thin layer of aortic endothelial cells. Tunica media is a thick layer 
containing aortic smooth muscle cells. Tunica externa contains fibrous connective tissue and 
the external layer of serosa contains a thin film of epithelial cells. Thus, it is important to 
realize that conventional techniques that have employed cell-seeding on a pre-formed 
polymeric conduit to facilitate growth of vascular networks may not entirely allow control 
over the various layers and cellular penetration. Novel rapid prototyping techniques with 
microscale control over the various layers and vasculature geometry may show to be 
promising in engineering vascular networks.   
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Tissue engineering of skeletal muscle and neural tissues are also equally challenging 
and important. In nerve guides or guidance channels, direct axons sprouting from the 
proximal nerve end provide a conduit from secreted growth factors and reduce scar tissue. 
Neurons patterned into nerve fascicles or bundles that match with the served nerve stumps 
can potentially aid in the regeneration of damaged peripheral nerves.102, 103  
Each tissue and organ in the human body has their own unique geometry which varies 
in size between individuals undermines the applicability of most conventional fabrication 
techniques. Conventional techniques have several issues with inadvertent residual solvents, 
high dependency and sensitivity to manual skills, experiences and procedures, poor 
consistency and poor repeatability. Additionally, they offer poor flexibility in producing 
complex macro-architectures. Novel tissue engineering approaches are required to address 
issues facing conventional techniques and permit scale-up and speed of development of  
functional three-dimensional networks to replace failed tissue.  
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Figure 9: Schematic of the various layers present in a human artery and vein.101 
 
 
Figure 10.  Repeating unit in Mytilus edulis foot protein-1.116 
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1.10 Bioadhesives and Wound-Closures 
Conventional wound closure techniques include use of sutures, staples, and pins. 
Closure of soft organs such as kidneys, blood vessels, and tendons remain quite difficult 
using conventional techniques. An alternative must allow rapid curing and hold tissue 
together until the defect is healed. In addition, the adhesive must be biodegradable, non-
immunogenic, and non-toxic. Tissue sealants derived from cyanoacrylate esters 
(Dermabond®, Indermil®, Nexaband®, and Vetbond®) are often used in repairing Achilles 
tendons, tooth enamel, corneas, and skin.104-106 However, these volatile cyanocrylates have 
demonstrated dose-dependent toxicity, carcinogenic properties and may result in skin 
allergies and respiratory ailments.107-109 Formaldehyde, a common constituent of synthetic 
adhesives, has been associated with nasopharyngeal cancer, leukemia, and sinonasal 
adenocarcinoma.. Fibrin sealants (derived from human blood coagulation factors) have also 
been considered for use in a variety of surgical and endoscopic applications in soft tissues.110 
However, fibrin adhesive is ineffective for supporting large tensile load and infections may 
be transmitted from the blood source. Next-generation bioadhesives are currently being 
developed to preserve the advantages of conventional cyanoacrylate adhesives, while 
lowering the exposure hazards and illness-associated with these materials. 
Marine mussel adhesive protein is a formaldehyde-free natural adhesive that has 
gained great interest in the scientific community.111-115 Mussels are sedentary mollusks that 
inhabit the turbulent environment of the intertidal zone; they attach to underwater surfaces by 
means of a byssus. This attachment plaque connects the mussel “foot” with the underwater 
surface, and contains a bundle of 5–50 mm long silky threads. Each thread consists of a 
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fibrous collagenous core coated with mussel adhesive proteins. Each mussel species has 
developed unique adhesive proteins. 
Mytilus edulis, a blue mussel used in this study produces five unique proteins, which 
are referred to as Mytilus edulis foot protein-1 (Mefp-1) to Mytilus edulis foot protein-5 
(Mefp-5).116-119 Mytilus edulis foot protein-1, a ~110 kDa material contains roughly 20 % 
lysine; 15% 3,4-dihydroxyphenylalanine (L-DOPA); and 30-50%  hydroxyproline, threonine, 
and tyrosine. These amino acids form hexapeptide and decapeptide (e.g., (Ala-Lys-Pro-Ser-
(Tyr/DOPA)-Hyp-Hyp-Thr-DOPA-Lys)) motifs that that may repeat up to eighty times 
within the mussel adhesive protein structure. The highly conserved Mefp-1 structure exhibits 
an open conformation with little secondary structure.  
Mussel adhesive proteins provide high strength adhesion to a wide variety of metals 
and polymers in aqueous environments, and may be an ideal replacement for synthetic 
adhesives in several technological applications. DOPA (3,4-dihydroxyphenlylalanine) is a 
common constituent of the Mytilus edulis and is distributed with the mussel proteins along 
the mussel plaque and bysall threads.120 DOPA is also thought to drive the adhesion of the 
mussel plaque to the interfacem by a metal-mediated catechol complexation process.121-123  
The phenolic hydroxyl groups in DOPA can form strong hydrogen bonds with a variety of 
substrates and chelate with metal ions. These interactions allow Mefp-1 to adsorb to several 
classes of materials, including pure metals, metal oxides, polymers, and glasses.124 In 
addition, the DOPA group can be oxidized by dissolved oxygen, chemical oxidizing 
reagents, alkaline environments (>8.5), or enzymes (e.g., catechol oxidase) to form 
orthoquinones. Orthoquinone groups have shown to react with lysine residues in neighboring 
Mefp chains to increase Mefp crosslinking. The resulting water-insoluble, three-dimensional 
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networks exhibit extremely high cohesive strength, water impermeability, and multilayer 
morphologies.125 
Unfortunately, mussel adhesive proteins can only be obtained from mussels in very 
small quantities; 10,000 mussels are needed to extract just one gram of protein. As a result, 
isolation of mussel adhesive proteins are prohibitively expensive.111-115 Recombinant 
proteins, synthetic polypeptides, and modified polymeric systems have been developed that 
reproduce the properties of natural mussel adhesive proteins.126-128 Another approach may 
involve the use of novel techniques to process naturally derived mussel adhesive protein in 
an efficient and economical manner. 
In a rapidly growing field of biomedical engineering there is an imminent need for 
novel CAD/CAM rapid prototyping technology that offer higher degrees of freedom than 
conventional technology. This dissertation details the development of novel CAD/CAM 
rapid prototyping technologies for various biomedical applications. Ahead, chapter two 
presents the materials and methods used in developing these technologies. Chapter three 
presents the results and discussion from the various research and development steps 
involved. The final chapter presents a summary of the developments and steps for future 
directions. 
 
 
CHAPTER 2 
MATERIALS AND METHODS 
 
2.1 2PP – TWO-PHOTON POLYMERIZATION 
The various materials and methodologies used in the development of two-photon 
polymerization (2PP) for biomedical applications are described ahead. 
 
2.1.1 Photopolymers 
Three different classes of low-shrinkage UV-sensitive photopolymers were used in 
this study. Ormocomp® or Ormocer® (Fraunhofer-Institut für Silicatforschung, Wurzburg, 
Germany) is a polymer-ceramic hybrid material with refractive index of 1.520 at 589 nm.129 
SR610  or ‘PEG (600) diacrylate’ (Sartomer, Exton, PA, USA) is a water-soluble monomer 
with refractive index of 1.468.130 SR499  or ‘ethoxylated(6) trimethylolpropane triacrylate’ 
(Sartomer, Exton, PA, USA) is a trifunctional oligoether acrylate monomer with heat and 
abrasion resistance properties. 1.8% Irgacure® 369 (Ciba Specialty Chemicals, Basel, 
Switzerland) was used as the photoinitiator for the photopolymers. 
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2.1.2 CAD/CAM Microfabrication Setup 
Figure 11 contains a schematic of the 2PP rapid prototyping setup. Titanium: sapphire 
oscillator (80fs, 94 MHz) was used as the laser source for two-photon polymerization. The 
laser was analyzed using a spectrum analyzer and tuned to operate at wavelength of 780 nm 
and power of approximately 450 mW. An acousto-optical-modulator (AOM) was used as a 
shutter to control the on-off state during fabrication. The λ/2 wave-plate (WP) was used in 
combination with the polarization-sensitive beam-splitter to control the average power of the 
input beam. The beam shape was expanded using a telescope lens setup and a high NA 
objective was used to tightly focus the beam within the liquid resin. A CCD camera was used 
to observe the two-photon polymerization process. A CAD module, a galvoscanner (ScanLab 
AG, Munich, Germany) and a micropositioning system (Physik Instrumente GmbH, 
Karlsruhe, Germany) was used to integrate the three-dimensional microfabrication process.  
Polymerization of the liquid resin occurred along the trace of the laser focus. Post-
fabrication, the non-irradiated resin was washed away using a 1:1 solution of 4-methyl-two-
penthanone and isopropanol. Three-dimensional structures of Lego®-like scaffolds, 
microneedles and ossicular replacement prostheses (similar to TORP prosthesis (Kurz 
Medical Inc., Dusslingen, Germany)) were developed.  Microneedles for transdermal 
administration were fabricated on laser perforated glass substrates with holes aligned to the 
microneedle channels.  The prototypes were UV sterilized prior to characterization. 
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Figure 11. Schematic of the 2PP setup for microfabrication of medical devices. 
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2.1.3 Microscopy 
A Nikon TE2000U (Nikon, Melville, NY, USA) inverted microscope equipped with an 
OrcaER camera was used to record DIC/fluorescence micrographs from the sectioned skin 
samples containing amino (PEG) quantum dots and fluorescein-biotin. Fluorescent-stained 
viable cells were examined with an LSM 510 confocal microscope (Carl Zeiss Inc., 
Oberkochen, Germany). 
 Scanning electron microscopy (SEM) was performed at the Analytical 
Instrumentation Facility (NCSU-AIF, Raleigh, NC, USA) using a Hitachi S-3200 SEM 
operating at 5 kV. Surface morphologies of the thin-film photopolymer substrates were 
examined using an Atomic Force Microscope operated in the tapping mode. The AFM 
images were recorded in the lateral force measurement mode and height mode (z-range of 25 
nm) with an x-y scan range of 25 μm.  
 
2.1.4 Nanoindentation Study 
A Nano-Indenter XP instrument (MTS Systems, Oak Ridge, TN, USA) was used to 
carry out indentation tests in order to measure the elastic modulus (E) and the hardness (H) of 
the materials. Based on the maximum load applied, the indentation depth, and the slope of 
the unloading curve, the hardness and elastic modulus values under different maximum load 
values were calculated. Thin-film samples of the three photopolymers were prepared by 
sandwiching the polymers between two glass coverslips followed by UV curing for 30 
minutes. Prior to indentation tests, one coverslip was carefully removed using X-Acto knife 
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to expose the film. Indentation tests were performed by the Nano-Indenter XP with a 
diamond Berkovich tip at nine sites in a clean area on the surface of each sample, which 
made a three-by-three matrix with 200 μm spacing. The indentation test consisted of ten 
maximum load cycles in each site, starting from 25 μN and up to 12.6 mN, doubling the load 
after each cycle. Each cycle consisted of five punches to the maximum load followed by 
immediate withdrawing, and then indented to the maximum load followed by 180 seconds 
holding before unloading. The same protocol was used to test the surface of the ear-
prosthesis. 
 
2.1.5 Cell-growth and Fluorescent Staining  
Cell growth and viability studies were performed using B35 neuroblast-like cells for 
tissue engineering scaffolds and HT1080 epithelial-like cells for microneedle devices. B35 
rat neuroblast clonal cells and HT1080 human fibrosarcoma epithelial-like cells were 
obtained from American Type Culture Collection (Manassas, VA, USA). They were sub-
cultured in a culture medium, which contained Dulbecco’s Modified Eagle Medium 
supplemented with 10% heat inactivated fetal bovine serum and 2 mM L-glutamine. The 
cells in media were stored in a 37 °C, 95% air, 5% CO2 culture incubator, and re-suspended 
when the cultures reached 70% confluence. One milliliter of non-diluted extra-cellular matrix 
was spin-coated at 220 g for 5 minutes, and was then allowed to cross-link. The cells were 
then incubated on sterile polystyrene Petri dishes, which contained extra-cellular matrix, 
ECM® (American Type Culture Collection, Manassas, VA, USA) at one end and the 
Ormocer® structures at the other end.  
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Fluorescent and live/dead cell staining kits (Biovision Inc., Mountain View, CA, USA) 
were used to image the cells. The live/dead cell staining solution was pipetted over the extra-
cellular matrix, and the solution was allowed to incubate for 15 minutes. Live-dyeTM stained 
living nuclei a green color, and propidium iodide caused dead cells to fluoresce a red color. 
The stained cells were viewed with an inverted optical microscope and a digital still camera 
with an epi-fluorescence attachment. For cytoskeletal staining, cells were first incubated in 
0.2% Triton X-100 (Sigma–Aldrich Company, St. Louis, MO, USA) for 1 min at room 
temperature. The cells were then washed three times with phosphate buffered solution (PBS). 
Cells were then incubated with phalloidin (Invitrogen Corporation, Eugene, OR, USA) in 
PBS (diluted 1:150) for 20 min at room temperature. DAPI develops fluorescent complexes 
through intercalation and binding processes with adenine–thymine and adenine–uracil base 
pairs in double-stranded DNA. After washing three times with PBS, cells were incubated in a 
10 mM solution of 40-6-diamidino-2-phenylindole (Invitrogen Corp., Eugene, OR, USA) for 
5 minutes at room temperature. After incubation with the nuclear stain, the samples were 
washed twice with PBS and mounted on glass microscope slides with Fluoromount-G 
(Southern Biotechnology Associates Inc., Birmingham, AL, USA).  
 
2.1.6 HEK Cytotoxicity Study 
Thin-films of Ormocer®, SR610 and SR499 photopolymers and accompanying glass 
coverslips (as controls) were tested in triplicate for human epidermal keratinocyte (HEK) 
cytocompatibility. The polymers and controls were placed in plastic Petri dishes and exposed 
on both surfaces to UVB to sterilize. They were briefly rinsed in cell culture medium (KGM-
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2) and placed in 6-well plates with 2 ml of medium per well. Each plate contained one 
polymer type and control (n=3 wells glass control coverslips; n=3 wells polymer). HEK 
(100,000) were seeded in each well in 2 ml of medium. The medium was changed after 24 
hrs and the cells grown for an additional 48 hrs. The controls and the polymers were 
transferred to new 6-well plates and cell viability was determined by the MTT (3-[4,5-
dimethyl-2-thiazol]-2,5-diphenyl-2H-tetrazolium bromide) assay. MTT medium (2 mL; 0.5 
mg per ml KGM-2) was placed on the HEK for 3 hrs. The tetrazolium metabolized within the 
mitochondria of viable cells was extracted with isopropanol, the extracted solution in each 
well pipetted into a new 96-well plate (in duplicate), and absorbance determined 
spectrophotometrically at 550 nm in a microplate reader (Multiskan RC, Labsystems, 
Helsinki, Finland). 
 
2.1.7 Microneedles Study 
5X5 square arrays of 25 identical 500µm spaced needles were fabricated on glass 
cover slips by two photon polymerization of Ormocer® hybrid materials. A CAD program 
was used to modify the geometry of the microneedles to be fabricated. The fabrication time 
for a single microneedle was approximately two minutes. The average length of the 
microneedle design was 800µm with a base diameter of 150-300 µm. Ormocer® hollow 
microneedles of various aspect ratios such as 3:1, 3.5:1 and 4:1 were developed. 
Microneedles with off-center displacement of 0 µm, 1.4 µm, and 20.4 µm were also 
fabricated to study the processing and mechanical properties.  
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An ELF 3200 (Bose Corporation, Minnetonka, MN, USA) was used to study fracture 
and penetration of the microneedles. In these studies, 50 g and 500 g load cells were driven at 
0.008 mm/s displacement rate against pork tissue (Nahunta Pork, NC, USA) and Teflon® 
polytetrafluoroethylene (E.I. DuPont de Nemours Company, DE, USA) surfaces. A live video 
capture device was used to monitor microneedle penetration behavior. 
400 μm thick skin areas were removed from the back of pig as described in Chang & 
Riviere131 for the transdermal administration studies. The pigs used in this study were in 
accordance with animal care and guidelines approved by North Carolina State University 
(Raleigh, NC, USA). Microneedles fabricated on perforated glass substrates were used to 
transdermally administer quantum dots and fluorescein-conjugated biotin on porcine skin. 
The perforated glass substrate was sealed with plastic tubing and connected to a clamped 10 
μL 26G glass syringe (Hamilton Co., Reno, NV, USA). 2 μL of fluorescein-conjugated biotin 
(Pierce Biotechnology, Rockford, IL, USA) was carefully injected via the microneedles into 
porcine full-thickness skin patches. 2 μL of fluorescein-conjugated biotin was topically 
applied on skin surface to serve as control. Post-administration, the skin samples were frozen 
at –20 °C with time-delays of 5 minutes, 20 minutes and 60 minutes. In a separate trial, 2 μL 
of 8 µM Qdot® 655 ITK™ amino (PEG) quantum dots (Quantum Dot Corporation/ 
Invitrogen, Hayward, CA, USA) with emission maxima at 655 nm was carefully injected via 
the microneedles into porcine full-thickness skin patches. As previously, 2 μL of amino 
(PEG) quantum dot solution was topically applied on skin surface to serve as control. The 
skin samples were frozen at 5 minutes and 60 minutes at –20 °C. The skin samples were 
sectioned at 20 μm on a cryostat and the samples were stored at –20 °C prior to imaging.  
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2.1.8 Implantation of Ossicular Replacement Prosthesis 
Ossicular replacement prostheses (similar to TORP prosthesis (Kurz Medical Inc., 
Dusslingen, Germany)) were developed using 2PP. Implantation of Ormocer® ossicular 
replacement prostheses were performed into the right ear of a commercially obtained un-
frozen human head. Optical micrographs were recorded at the various stages of the 
procedure. First, the chorda tympani was partly removed. This was followed by the removal 
of the incus and the head of the stapes using surgical tools. The Ormocer® prosthesis was 
carefully lined against the posterior canal wall. Finally, the implant was positioned in situ 
with the tympanomeatal flap raised anteriorly. 
 
 
 
 
 
 
 
 
 
 
 
39 
2.2 MDW – MAPLE DIRECT WRITE 
The various materials and methodologies used in the study of matrix-assisted pulsed 
laser evaporation direct-write (MDW) are described ahead. 
 
2.2.1 UV Absorbing Polymer 
An intermediate UV-absorbing (193 nm) release layer was developed using triazene 
polymer.132 The structure of triazene polymer (TP) is shown in Figure 12. 
 
2.2.2 Bioceramics 
Hydroxyapatite (Ca10(PO4)6(OH)2) of 500 nm average particle size and zirconia 
(ZrO2) of 0.33 to 2.19 particle size powders (Alfa Aesar, MA, USA) were used for the study. 
The bioceramic powders were ground using a mortar and pestle and solvated in 50:50 
glycerol:water matrices to create slurries for spin coating on quartz ribbons.  
 
2.2.3 Biologics  
MG63 osteosarcoma cells (American Type Culture Collection Manassas,, VA, USA) 
were used for the bioceramic study. They were sub-cultured in a Eagle’s minimum essential 
medium (EMEM) media containing 2 mM L-glutamine, 1.5 g/L sodium bicarbonate, 0.1 mM 
non-essential amino acids, 1.0 mM sodium pyruvate, 10% heat-inactivated fetal bovine 
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serum, and 1% antibiotic syrup. B35 neuroblast clonal cells (American Type Culture 
Collection, Manassas, VA, USA) were used for the MDW study using triazene polymer. The 
cells were sub-cultured in a Dulbecco's modified Eagle's medium (DMEM) media, 10% heat-
inactivated fetal bovine serum, and 1% antibiotic syrup. Sub-confluent cells are trypsinized 
and split 1:5 to maintain division of the cell line and avoid differentiation. The cells were 
stored in a 37o C, 5% CO2 culture incubator.  Extracellular matrix (ECM®) (American Type 
Culture Collection, Manassas, VA, USA) solutions were used to coat the ribbons and the 
substrates for the MDW experiments.  
 
2.2.4 MDW Microfabrication  
In MDW microfabrication and biomaterial patterning, an ArF pulsed excimer laser 
(λ=193 nm, R=10 Hz) was used as the source light. The laser was focused onto a receiving 
plane using optics coated with UV reflective material. The biomaterial used for patterning 
was spin-coated on a quartz disc “ribbon”, which was placed directly above a receiving 
substrate which was held using a vacuum chuck (Figure 13). The gap between the ribbon and 
substrate was controlled using a stage z-translation. The CAD/CAM program for the 
translation movement was synchronized with the laser parameters to generate the desired 
pattern. The translation movements were achieved using Aerotech U500 (Aerotech, 
Pittsburgh, PA, USA) powered x-y translation stages. The transfer process was observed 
using an inverted lens camera focused on the ribbon plane. The fluence (laser energy density) 
was systematically varied to determine the threshold level for the biomaterial. All 
experiments were performed in air and at room temperature.  
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Figure 12. Structure of triazene polymer used as a release layer. 
 
 
 
Figure 13. Schematic of the MDW process. 
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“Ribbons” were prepared by spin-coating the triazene polymer (TP) on clean one inch 
quartz discs to thicknesses of 60 nm, 70 nm, 80 nm, 90 nm, 110 nm and 140 nm. Ribbon and 
receiving substrates were then spin coated with ECM® at 1000 rpm for ten seconds. Sub-
confluent B35 rat neuroblast-like cells were trypsinized, and centrifuged at 220 g for three 
minutes. The concentrated cell pellet was reconstituted to obtain approximately 107 cells/ml. 
250 μl of this solution was pipetted onto the ribbon and incubated for 10 minutes to allow 
attachment to ECM layer. Post transfer, the ribbon and the substrate were stored in separate 
Petri dishes containing pre-warmed media. The cells on the substrates were observed for 
viability and proliferation at time intervals of 0-3 h, 3-6 h, 6-12 h, 12-24 h, 24-48 h.  
MDW of bioceramics-osteosarcoma cells were performed without the TP layer. ECM 
solution was slowly warmed from –20 °C to 0-4 °C in order to avoid rapid polymerization 
and 500 μL was spin-coated was spin coated on sterilized one inch quartz ribbons and glass 
substrates for ten seconds at 1000 rpm. The ribbons and substrates were incubated to allow 
cross-linking of the matrix proteins. Hydroxyapatite and zirconia slurries (concentrations of 
sixty weight percent and seventy weight percent) were then spin coated at 1000 rpm for ten 
seconds onto these ribbons.  
As previously, sub-confluent MG63 osteosarcoma cells were reconstituted to 
approximately 107 cells/mL and 250 μL pipetted onto the ribbons. The minimum laser 
energy for MDW transfer was determined by systematically increasing the laser fluence and 
simultaneously observing the ablation using the digital camera. After MDW transfer, the 
ribbon and the substrate were stored in separate Petri dishes containing pre-warmed EMEM 
(EBSS) media.  
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2.2.5 Microscopy 
The ribbon and substrates were stored in separate Petri dishes containing pre-warmed 
media, after transfer. The cells on the substrates were observed for viability and proliferation 
at various time points such as 0-3 h, 3-6 h, 6-12 h, 12-24 h, 24-48 h using an inverted 
Olympus X71 microscope with epi-fluorescence attachment. A live/dead stain (Biovision 
Research Products, CA, USA) was used to examine the cells. The propidium iodide within 
the staining solution caused non-viable cells to fluoresce red and the Live-dyeTM caused the 
viable cells to fluoresce green. Optical microscopy was also used to examine the feature sizes 
in the patterns generated. 
Hitachi S800 scanning electron microscope (Hitachi High Technologies, Tokyo, 
Japan) was used to examine the microstructure of the MDW-transferred bioceramic patterns. 
X-ray diffraction was performed to determine the composition, phase, and crystallinity of the 
transferred material. 
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2.3 CLM – CAD/CAM LASER MICROMACHINING 
The various materials and methodologies used in the study of CAD/CAM laser 
micromachining are described ahead. 
 
2.3.1 Materials and Biologics 
Polished Si (111) wafers were used for the preliminary ablation studies. 1-2% agarose 
gel was prepared by hydrating 0.5 g of electrophoresis-grade agarose powder (Sigma Aldrich, 
MO, USA).   
C2C12 mouse myoblast cells, A431 human skin epithelial carcinoma cells, and B35 
neuroblast clonal cells (American Type Culture Collection, Manassas, VA, USA) were grown 
in tissue culture flasks, trypsinized, centrifuged, and re-suspended in 90% Dulbecco’s 
Modified Eagle’s Medium (DMEM) supplemented with 10% fetal bovine serum and 1% 
penicillin–streptomycin–glutamine). HAAE-1 human aortic endothelial cells and HA-VSMC 
human aortic smooth muscle cells were obtained from the Wistar Special Collection 
(American Type Culture Collection, Manassas, VA, USA). These two cell-lines were used for 
the vascular network development. All cells were sub-cultured and incubated at 37 °C, 5% 
CO2. Matrigel® (Becton-Dickinson, NJ, USA), HA587 human soluble elastin (Elastin, 
products, MI, USA), vascular endothelial growth factor (VEGF) and heparin (Sigma-Aldrich, 
MO, USA) were used in the UV-sterilized matrix to study the effect on the growth and 
proliferation of the cells. 
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2.3.2 CLM Microfabrication 
The setup for CLM microfabrication was similar to the MDW setup. Figure 14 
contains the schematic of the CLM setup. An ArF pulsed excimer laser operating at 193 nm 
was used as a source light. Fused silica biconvex lenses L1 and L2 were used in a telescopic 
to lower the primary spot size of the laser. Apertures A1 and A2 were used to further reduce 
the laser spot size and allow alignment. UV-dielectric mirrors M1 and M2 were used to reflect 
the laser light at 45° incident angle. A 10x UV-objective (O) was used to focus the laser 
beam to spot-size of up to 5 μm. A CCD camera was aligned with the mirrors and objective 
to monitor the micromachining process.   
The micropositioning module was developed to convert the CAD geometry and 
synchronize the x-y-z translation movement with the laser parameters. As laser interaction 
with each material is unique, the ablation characteristic for every new material was studied as 
a function of laser energy, spot-size, and repetition. This allowed calibration of the system 
for a unique material. 
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Figure 14. Schematic of the CLM process and setup.  
 
 
Figure 15. Image of the CLM Setup with key parts labeled. 
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2.3.3 Cytotoxicity Study 
In order to assess the effect of VEGF and heparin on cell-viability, HAAE-1 and HA-
VSMC cells were seeded in 24-well culture plates (~ 5000 cells/well) containing VEGF (1, 
10, 100, 1000 ng/ml) and heparin (1, 10, 100, 1000 units/ml) separately using plain media as 
controls with n=4.  At 24 hours, the cells were exposed to media (control) and assayed for 
MTT. The cells were incubated in MTT (3-[4,5-dimethyl-2-thiazol]-2,5-diphenyl-2H-
tetrazolium bromide) medium (0.5 mg/ml) for 4 h, the tetrazolium metabolized within the 
mitochondria extracted, and absorbance quantified. The absorbance was determined 
spectrophotometrically at 550 nm (Multiskan RC Labsystems, Helsinki, Finland). 
 
2.3.4 Development of Tissue Networks 
Once the laser ablation characteristics were established, various CAD/CAM patterns 
were developed. Channels 60 to 400 μm wide and one cm long were developed for the 
neuroblast, myoblast and epithelial cell study. Each channel was provided with a reservoir to 
allow easy flow of scaffold material and growth factor/proteins. Non-diluted extracellular 
matrix solution was micro-pipetted into the channels and allowed to polymerize into a thin 
film in the channel. The growth and proliferation of the cells within the channels were 
studied.  
In order to allow development of multi-layered vascular networks, a reservoir-ring 
type design was developed (Figure 16). Each ring (representing each layer) was connected to 
an independent reservoir to allow selective flow of nutrients/growth-factors. The 
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micromachined hydrogels were filled with growth factors established from the 
cytotoxicity/MTT analysis to allow controlled proliferation and growth of cells within the 
layers. The growth of cells within the network was monitored. The full-grown tissue network 
after delamination from hydrogel substrate was re-suspended in fresh media. 
 
2.3.5 Microscopy  
The growth and proliferation of the cells in micromachined scaffolds were observed 
with a Meiji 5500 inverted optical microscope (Meiji Techno, Santa Clara, CA, USA) and a 
digital still camera with an epi-fluorescence attachment. A live/dead cell staining kit 
(Invitrogen, CA, USA) was used to stain the cells (dead cells red and live nuclei green).  
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Figure 16. Reservoir-ring design for each layer of vascular network.  
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2.4 PIT - PIEZOELECTRIC INK-JET TECHNOLOGY 
The various materials and methodologies used in the study of piezoelectric ink-jet 
technology are described ahead. 
 
2.4.1 Materials 
Rhodamine-conjugated streptavidin and fluorescein-conjugated biotin (Pierce 
Chemicals, IL, USA) were solvated in phosphate buffer saline solution to a 1.6 μM solution. 
1% of polysorbate 20 surfactant (Fisher Science, NJ, USA) was added to isolate the water-
soluble protein. 
Mussel proteins (Mefp-1 and Mefp-2) were extracted from marine mussel Mytilus 
edulis as described previously.133 Mytilus edulis mussel proteins (80% Mefp-1 and 20% 
Mefp-2) solvated in water with a DOPA concentration of 0.16 mM was obtained from 
Wilker lab (Purdue University, West Lafayette, IN, USA). In order to study iron-induced 
cross-linking, FeCl3 solution was prepared in series dilution to obtain ratios of 1:1 Fe:DOPA, 
10:1 Fe:DOPA, and 100:1 Fe:DOPA. Cell-takTM cell and tissue adhesive containing 
polyphelolic proteins derived from Mytilus edulis mussels were obtained from BD 
Biosciences (Franklin lakes, NJ, USA). N-butyl cyanoacrylate (Vetbond® Tissue Adhesive) 
was obtained from 3M (St. Paul, MN, USA). 2-octyl cyanoacrylate (Nexaband® Liquid 
Topical Tissue Adhesive) was obtained from Abbott Laboratories (North Chicago, IL, USA). 
Ethyl cyanoacrylate (Loctite® Quick Set Adhesive) was obtained from Ted Pella (Redding, 
CA, USA).  PEG synthetic hydrogel adhesive CoSeal® surgical sealant was obtained from 
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Baxter Healthcare (Fremont, CA, USA) and contained two synthetic polyethylene glycols 
(PEGs) buffer solutions that readily formed a hydrogel upon mixing.  
 
2.4.2 PIT Micropatterning  
The CAD/CAM piezoelectric ink-jet printer (FujiFilm-Dimatix, SantaClara, CA) was 
based on a cartridge print-head system: fluid was injected into the fluid module and then the 
fluid module was attached to the jetting module to form a sealed cartridge. The ink jet print-
head itself was a silicon die that consists of 16 individually addressable jets, which were 
spaced 254 μm apart. The effective nozzle diameter was 21.5 μm, which provided droplets 
that were approximately 10 pL in volume.  
The printer was used to dispense picoliter quantities of adhesive solutions in a 
predefined pattern onto a variety of substrates (Si (111), borosilicate glass, dermatomed pig-
skin and KCl) at 25 °C and 40% relative humidity. The viscosities of solutions were 
measured prior to jetting, using a Brookfield viscometer (Brookfield Engineering, 
Middleboro, MA, USA). All solutions (except Loctite® monomer) were within jetting 
viscosity range (5-15 Cps).The waveform pulse shape (amplitude, slew rate and duration), 
frequency and voltage were optimized for all the bioadhesive solutions independently 
(sample wave-form shown in Figure 19). The mussel protein solution was ink-jetted at 
voltages (10, 20, 30, and 40 V) to study the effect of voltage on protein-structure. The droplet 
flight (distance traveled) from the nozzle was recorded using an ultra-fast camera. The 
images were recorded at various time-intervals and various voltages.  
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Figure 17. Image of the piezoelectric printer and cartridge. 
 
 
Figure 18. Schematic of a piezoelectric print-head. 
 
 
Figure 19. A sample jetting wave-form for 15V peak supply. 
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The adhesive and protein solutions were also patterned into a 1 cm2 area (with 10 μL 
constant volume) on Si (111) substrates for optical/AFM/XPS/contact-angle measurements, 
on full-thickness porcine skin for adhesion testing, and on KCl/AgCl for FTIR 
measurements. Vetbond® and Nexaband® tissue adhesives were ink-jetted in their monomer 
liquid form. Loctite® quick set adhesive composed of ethyl cyanoacrylate was not compatible 
with the ink-jet system due to the high viscosity and quick-setting properties of the monomer. 
The Loctite® resin was drop-cast into thin-film samples and used as a control for comparative 
study. 
In order to study iron-induced cross-linking, mussel protein solution (containing 80% 
Mefp-1, 20% Mefp-2 and 0.16 mM DOPA) was ink-jetted, followed by a layer of FeCl3 
solution (at varying concentrations to reach 1:1, 10:1, 100:1 Fe: DOPA respectively) using 
the same pattern. Drop-cast samples of the protein solution were prepared for the FTIR study. 
For CoSeal® micropatterning, the liquid component consisted of dilute HCl solution and a 
sodium phosphate/sodium carbonate solution in two syringes. The liquid solutions and PEG 
powder components from the syringe assembly were carefully removed and transferred to 
sterile vials. The PEG powder component (part I) was dissolved in the sodium 
carbonate/sodium phosphate solution and transferred to an ink-jet cartridge. Part II of the 
solution was transferred into a separate cartridge to allow subsequent jetting of the additional 
layer to control the formation of CoSeal® hydrogel. 
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2.4.3 Spectroscopy Study 
A drop-cast sample of the bioadhesives and protein solutions were prepared to 
compare the absorption peaks to the ink jet deposited material. Fourier transform infrared 
spectroscopy (FTIR) was performed using a Mattson 5000 series (Madison Instruments, WI, 
USA) spectrometer with 4 cm-1 resolution. The absorption spectra (4000-500 cm-1) were 
recorded for the ink-jetted and drop-cast materials. 
X-ray photoelectron spectroscopy (XPS) data was acquired using a Riber dual Mg/Al 
anode source Auger and photoelectron separation at 12kV/14mA beam energy, 1mm spot 
size, 0.3 - 4.0 eV resolution and solid angle at 6% of 2(pi).  
 
2.4.4 Mechanical and Surface Testing  
Adhesion studies were performed on full-thickness porcine skin and Al substrates 
using an Instron 8501 uniaxial tensile test system (Instron, Norwold, MA, USA). The load at 
failure and mode of failure was assessed. The tests were carried out six times for each 
sample, and a statistical analysis was performed using Student's t-test. Contact-angle studies 
were performed using a goniometer, a syringe, an aligned digital zoom camera and an 
illumination source. Distilled water was used as the liquid source against protein-coated Si 
substrates. 
A Nano-Indenter XP instrument (MTS Systems, Oak Ridge, TN, USA) was used to 
carry out indentation tests using Continuous Stiffness Measurement (CSM) technique in 
order to measure the elastic modulus (E) and the hardness (H) of the materials. In addition to 
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measuring the indentation depth under the increasing load, a lock-in amplifier was used to 
measure the differentiation of loading force over the vertical displacement at the vibrating 
frequency during the indenting. It eliminates the need of unloading to obtain the slope of the 
unloading curve at the turning point to calculate the elastic modulus and hardness, thus 
measuring the modulus and hardness continuously instead of at a discrete set of loads and 
depths. The tests were performed at four different sites with a spacing of 1000 μm at a depth 
up to 500 nm on the surface of Vetbond® and Loctite® adhesives. For the CoSeal® sample, a 
total of five tests were performed at the scattered sites on the surface with spacing from 100 
μm to 6 mm at a depth up to 750 nm. 
 
2.4.5 HAAE-1 Cytotoxicity Study 
Cytotoxic analysis of bioadhesives was performed using HAAE-1 human aortic 
endothelial cells (American Type Culture Collection, Manassas, VA, USA). HAAE-1 cells 
were seeded in 24-well culture plates (~ 5000 cells/well) containing equal amounts of ink-
jetted bioadhesives (n=4). Cells growing on empty wells with plain media were used as 
controls.  At 24 hours, the cells were exposed to media (control) and assayed for MTT. The 
cells were incubated in MTT (3-[4,5-dimethyl-2-thiazol]-2,5-diphenyl-2H-tetrazolium 
bromide) medium (0.5 mg/ml) for 4 h, the tetrazolium metabolized within the mitochondria 
extracted, and absorbance quantified. The absorbance was determined spectrophotometrically 
at 550 nm (Multiskan RC Labsystems, Helsinki, Finland). 
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2.4.6 Microscopy 
Optical/fluorescent microscopy of the micropatterned substrates were performed 
using a Leica DLMB upright microscope (Leica Microsystems, IL, USA). Optical imaging of 
the deposited adhesives was performed using an Olympus upright microscope (Olympus Inc., 
Center Valley, PA, USA).  Scanning electron microscopy (SEM) was performed at the 
Analytical Instrumentation Facility (NCSU-AIF, Raleigh, NC, USA) using a Hitachi S-3200 
SEM operating at 5KV. Atomic force microscopy (AFM) was performed using an N-scriptor 
system (Nanoink, IL, USA) with a scanning head providing a maximum scan range of 80 x 80 
μm2. The imaging was performed at 2 Hz in the contact mode using silicon nitride 
cantilevers (spring constant: 0.06 Nm-1) with integrated pyramidal tips. Linear and 3-D 
profiles of the surface scans were obtained using Nanorule data analysis.  
 
 
 
 
 
 
CHAPTER 3 
RESULTS AND DISCUSSIONS 
  
3.1 2PP – TWO-PHOTON POLYMERIZATION 
The two photon absorption process has a quadratic dependence on laser intensity, 
which allows high absorption at tightly focused area within the liquid resin. Negligible 
absorption occurs except in the immediate vicinity of the focal volume of the light beam. 
This phenomenon allows microscale polymerization in three-dimensional space, unlike 
stereolithography (a layer by layer approach). All three photopolymers (Ormocer®, SR610, 
and SR499) were compatible with the two-photon polymerization process. Two-photon 
polymerization was used to develop CAD/CAM micromedical devices such as Lego-like 
scaffolds, microneedles for transdermal drug-delivery and ossicular replacement prosthesis.  
Figure 20 contains a scanning electron micrograph of a 6x5 array of off-centered Ormocer® 
microneedles with approximate base diameters of 290 μm and length of 650 μm.  
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Figure 20. Scanning electron micrograph of a 6x5 array of off-centered Ormocer® 
microneedles fabricated by two-photon polymerization. Scale bar equals 1 mm. 
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3.1.1 Nanoindentation Study 
Studying the mechanical properties of the photopolymers was important in order to 
establish their applicability in medical usage. Figure 21 contains the measured elastic 
modulus E and hardness H of the three samples (Ormocer®, SR499, and SR610). Significant 
viscocreep deformation as well as viscoelastic recovery was observed. The hardness and 
elastic modulus values started from high values at shallow depths, decreased dramatically 
with the increasing depth, and then stabilized at a value. The higher hardness and elastic 
modulus values at the surface were attributed to the ultraviolet curing process. There was a 
significant difference in mean hardness and modulus values between all three materials. 
Ormocer® showed highest values with mean hardness of approximately 90 MPa and mean 
modulus of approximately 2100 MPa at 2 μm indentation depths. SR499 or ethoxylated(6) 
trimethylolpropane triacrylate showed lowest values with mean hardness of approximately 
7.5 MPa and mean modulus of approximately 50 MPa. SR610 or PEG (600) diacrylate 
showed mean hardness of approximately 30 MPa and mean modulus of approximately 607 
MPa. The high hardness and modulus values in Ormocer® may be attributed to the presence 
of organically modified silicon alkoxides and the strong covalent bonds between the ceramic 
and polymer components that form during the two photon polymerization process. The 
mechanical properties may be further modified be varying the amount of organic network 
units, inorganic network units and fillers. 
Figure 22 contains atomic force micrographs (lateral force measurements, LFM and 
height scan, HTS) of the surface of the polymerized materials (Ormocer®, SR610, and 
SR499). The surface of Ormocer® showed to be significantly smoother and more uniform 
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than the other two polymers. The RMS roughness of the surface of Ormocer®, SR610, and 
SR499 were measured to be 0.651 nm, 1.25 nm, and 4.19 nm, respectively. 
The optical, chemical, and mechanical properties of Ormocer® demonstrate a large 
degree of variability. Ormocer® materials are optically transparent over the 400–1600 nm 
wavelength range.134 These materials demonstrate low optical losses in the near infrared 
range, with losses less than 0.06 dB/cm at 830 nm, and less than 0.6 dB/cm at 1550 nm. The 
refractive index of Ormocer® materials may be adjusted in the 1.47-1.56 range. Many 
materials prepared by sol–gel processing exhibit high (>20%) volume shrinkage during 
solvent removal, curing, and network densifying, which can lead to significant cracks, 
mechanical stresses, and other defects. Ormocer® materials exhibit far less shrinkage (~2%) 
than other sol-gel materials due to the stability of the inorganic Si–O–Si network and the 
inclusion of fillers.135 The density, Young’s modulus, thermal expansion coefficient, gas 
permeability, refractive index, and other properties of Ormocer® materials exhibit values 
between those of ceramics and those of polymers.136, 137 For example, the densities of 
Ormocer® materials (1.1- 1.6 g/cm3) are below the densities of oxide materials, but above the 
densities of organic polymers. In addition, Ormocer® materials demonstrate a high degree of 
flexural strength. Ormocer® materials demonstrate high adhesive strength to a variety of 
substrate materials, including metallized silicon wafers, inorganic glasses, and polymers.138 
Ormocer®- based matrix components (DefiniteTM) and Ormocer®- based light-curable dental 
composites (AdmiraTM) have been commercially available for use in restorative dentistry 
since 1988. In addition, carboxy-modified Ormocer® materials have been used as matrix 
materials in light-curable glass ionomer cements.139  
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X-ray diffraction was used to confirm that Ormocer® surfaces created using two 
photon induced polymerization exhibit an amorphous structure. The X-ray diffraction 
pattern, shown in Figure 23, also suggests that there is no separation between the inorganic 
and organic phases in the polymerized Ormocer® material. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
62 
 
 
Figure 21. Nanoindentation results of the photopolymers. A. Graph of hardness (MPa) vs. 
indentation depth (mm) of the photopolymers. B. Graph of modulus (MPa) vs. indentation 
depth (mm) of the photopolymers. Symbols “¡”, “S”, and “” represent values for 
Ormocer®, SR610 (PEG(600) diacrylate), and SR499 (Ethoxylated(6) trimethylolpropane 
triacrylate), respectively. Bars in graph A and graph B indicate standard deviation of mean 
hardness and modulus values, respectively. 
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Figure 22. Atomic force micrographs of the surface of A: Ormocer®, B: SR610 (PEG(600) 
diacrylate), and C: SR499 (Ethoxylated(6) trimethylolpropane triacrylate) recorded in 
tapping mode. Top row contains LFM (lateral force measurement) scan and bottom row 
contains HTS (height scan with z-range of 25 nm) of the three photopolymers for a range of 
25 μm x 25 μm. 
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Figure 23. X-ray diffraction pattern of two-photon polymerized Ormocer® surface. 
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3.1.2 HEK Cytotoxicity 
With the exception of SR610, which fragmented during the first medium rinse, the 
polymers were stable in cell culture medium. After 24 hours, the SR 610 fragments remained 
intact, while SR 499 detached from the coverslip. Cell growth on all controls and the 
Ormocer® polymer ranged from 65% to 80% confluency as determined with an inverted 
microscope. While the Ormocer® substrates (Figure 24A) and the controls (Figure 24D) 
supported human epidermal keratinocyte (HEK) growth, little growth was observed on the 
SR610 (Figure 24B) and SR499 (Figure 24C) substrates. Figure 25 contains the MTT 
viability for the HEK of the three polymers and the controls. The polymers SR610 and 
SR499 demonstrated to be a very poor substrate for HEK growth with only 14% and 27% 
viability, and was statistically significant at (p<0.05), relative to controls.  On the other hand, 
HEK growth on Ormocer® substrates was similar to controls and not significantly different 
(p<0.05). Previous biological studies, including the ISO 10933-5 cytotoxicity (elution) assay, 
have shown that Ormocer® materials are nontoxic and biologically inert.140, 141 
Ormocer® in comparison with SR499 and SR610 showed significantly superior 
mechanical strengths, surface properties and HEK cytocompatibility (Refer Table 2). Thus, 
Ormocer® was chosen for subsequent fabrication of Lego®-like scaffolds, microneedles and 
ossicular replacement prostheses using the two-photon polymerization technique.  
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Figure 24. Light micrograph of human epidermal keratinocytes on A: Ormocer®, B: SR610 
(PEG(600) diacrylate), C: SR499 (Ethoxylated(6) trimethylolpropane triacrylate), and D: 
control. Scale bar equals 50 μm. 
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Figure 25. MTT viability of human epidermal keratinocytes on Ormocer®, SR610 
(PEG(600) diacrylate), and SR499 (Ethoxylated(6) trimethylolpropane triacrylate) substrates 
relative to paired controls. Bars indicate standard deviation of mean viability. (s and t), (u 
and v) are significantly different (p<0.05). 
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Table 2. Comparison of properties of different classes of two-photon polymerizable 
materials. *HEK viability is relative to controls. 
Notation Monomer  Hardness (MPa) 
Modulus
(MPa) 
RMS 
Roughness 
(nm) 
HEK 
Viability 
(%)* 
Ormocer® 
Methyl-methacrylate 
and alkoxy-silane 
groups 
90 2100 0.65 95 
SR610 PEG(600) diacrylate 30 607 1.25 14 
SR499 
Ethoxylated(6) 
trimethylolpropane 
triacrylate 
7.5 50 4.19 27 
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3.1.3 Microfabrication of Lego®-like Scaffolds 
Two-photon polymerization was used to develop Lego®-like interlocking scaffolds 
for tissue engineering, which contain arrays of cylindrical pillar structures on both sides of a 
flat Ormocer® chip. These structures could be used either as free-standing scaffolds or 
stackable blocks for layer-by-layer replication of heterogeneous tissues. Figure 26 contains a 
CAD image and an optical micrograph of a free standing Lego®-like scaffold fabricated by 
two photon induced polymerization. The pillars were 75 μm in diameter and 20 μm in height, 
and can be observed in and out of focus on either side of the Ormocer® substrate.  
Figure 27 contains optical and fluorescence micrographs of live/dead-stained B35 
neuroblast-like cells encapsulating the pillars, 48 h after inoculation. Figure 28 contains 
fluorescent micrographs of B35 neuroblast-like cells on Ormocer® Lego®-like structures at 
several magnifications. The cytoskeleton is denoted by a green color, and the nuclei are 
denoted by a blue color. Live/dead assays were performed to determine the viability of 
epithelial-like and neuroblast-like cells. The optical fluorescence micrographs of live/dead 
assay-stained B35 neuroblast-like cells on Ormocer® surfaces are shown in Figure 29. 100% 
of the B35 neuroblast-like cells and HT1080 epithelial-like cells remained viable 48 h after 
inoculation on the Ormocer® substrates. The growth profiles of the cells are shown in Figure 
30. The number of live epithelial-like and neuroblast-like cells was found to gradually 
increase over time. No significant difference was noted between the growth rates for cells on 
the polystyrene, Ormocer® or extracellular matrix substrates at 96 h, when the cells were 
nearing confluency on the substrates. These results suggest that polymerized Ormocer® 
surfaces do not significantly impair cell viability or growth rates. 
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Figure 26. A: CAD image and B: optical micrograph of Ormocer® Lego®-like structure 
microfabricated by 2PP. Scale bar equals 50 μm. 
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Figure 27. Optical/fluorescent micrograph of B35 neuroblast-like cells on 75 μm Lego®-like 
structures, 48 h after seeding. Scale bar equals 20 μm. 
 
 
 
72 
 
 
Figure 28. Fluorescent micrographs at several magnifications of B35 neuroblast-like cells on 
Lego®-like Ormocer® structures 48 h after seeding. Scale bar equals 50 μm for A, B and 10 
μm for C, D. 
. 
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Figure 29. A) Optical micrograph and B) fluorescence micrograph of live/dead assay-stained 
B35 neuroblast-like cells on an Ormocer® surface, 48 hours after inoculation.                   
Scale bar equals 20 μm. 
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Figure 30. Growth profile of A: HT1080 human epithelial cells and B: B35 neuroblast-like 
cells on Ormocer® surfaces. Values expressed as mean ± standard deviation. 
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3.1.4 Microneedles Validation Study 
Ormocer® microneedle arrays were fabricated by two-photon polymerization in 
various geometries. Firstly, CAD images of the various designs were developed using 
AutoCAD® software. Figure 31 contains a few CAD images used for fabrication of 
microneedles with varying tip-sharpness. Tip sharpness was changed by adjusting the 
position of the channel relative to the central symmetry axis in the original design, as 
illustrated in Figure 32. These designs were developed to allow less than 5% tolerance and 
after compensating for polymer shrinkage. Figure 33A contains an Ormocer® off-centered 
microneedle with a base diameter of 150 µm, off-center displacement of 1.4 µm and a length 
of 550 µm. Figure 33B contains a 3x3 microneedle array that have off-center displacement of 
20.4 µm, base diameter of 150 µm and needle lengths of 550 µm.  
Scanning electron micrograph of Ormocer® hollow microneedles with 0 µm off-
center displacement and aspect ratios of 3:1, 3.5:1 and 4:1 is shown in Figure 34. The 
microneedle tapers linearly from the base to the tip and a ripple-like feature can be observed 
on the walls of the needles. This can be attributed to the layer by layer fabrication approach, 
and can be eliminated by increasing the number of the layers and reducing the distance 
between them. The aspect ratios were changed by changing the diameter of the base in the 
original design. However, the inner-channel diameter for flow remained constant for all the 
samples. The four openings visible at the base of the needle were connected to the channel. 
These designs were incorporated to allow rapid and efficient removal of the non-cross-linked 
polymer from the channel, since one end of the needle would be blocked by the substrate.  
Figure 35 contains image of microneedles developed with saw-toothed walls. Figure 36 
compares the size of microneedle arrays with a conventional hypodermic needle. 
 
76 
 
 
Figure 31. Computer aided design (CAD) of microneedles with varying geometry of tip-
sharpness and location of pore from centre. 
 
 
Figure 32. Scanning electron micrograph of Ormocer® microneedle with centre 
displacement of 0 µm, 1.4 µm, and 20.4 µm (left to right). 
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Figure 33. Scanning electron micrograph of A) a single 1.4 µm off-centered microneedle and 
B) 3x3 array of 1.4 µm off-centered microneedles fabricated by 2PP process. 
 
 
Figure 34. Scanning electron micrograph of Ormocer® hollow microneedles (0 µm off-
center displacement) with various aspect ratios such as 3:1, 3.5:1 and 4:1.                                  
Scale bar equals 50 μm. 
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Figure 35. Scanning electron micrograph of microneedles with saw-toothed walls. 
 
 
Figure 36. Optical micrograph of Ormocer® microneedle arrays compared with a 
hypodermic needle. Scale bar equals approximately 600 μm. 
 
 
 
 
 
 
79 
In developing microneedles, it was desirable to fabricate needles that required least 
loading during penetration of the skin. Flexibility of 2PP allows rapid iterations in fabrication 
of microneedles with complex geometries. In order to determine the effect of the needle tip 
sharpness, different needle arrays were tested against porcine fat and full-thickness skin. 
Porcine fat provided a uniform surface for testing compared with highly non-uniform skin. 
Figure 37 contains an optical micrograph of an off-centered microneedle on full-thickness 
skin with the various layers labeled. Depending on the load and control over z-axis, the 
microneedle developed may penetrate well into the dermis layers.  
Figure 38 contains load-displacement curves for microneedle arrays where the center 
of the channel was displaced by values indicated. The slopes on the curve may be divided 
into three regions, exhibiting different trends. The initial displacement occurred when the 
needles come in contact with the tissue and exerts pressure on it. Subsequently, the middle 
region contains information on the actual needle penetration through the sample. The initial 
‘dip’ the curve indicated the region where the load threshold on the surface of the tissue was 
reached. Here, the tissue was pierced by a few microneedles simultaneously. The value of the 
load at this point would represent the minimum load required to pierce the tissue surface. The 
final displacement in the curve indicated the contact with the cover slip containing 
microneedles.  
The microneedle with the 20.4 µm off-center location has the sharpest tip and the 
lowest value of penetration-threshold (load required to puncture) among the off-center 
geometries. Owing to the presence of methacrylate groups in the cross-linked Ormocer®, the 
structure stays somewhat elastic. During the test the tip bends even further, resulting in 
increased penetration resistance and therefore the larger values of load threshold for 
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penetrations. Similar load vs. displacement curves acquired for microneedles with different 
aspect ratios indicated a minor difference in the load values for different needles, but there 
was no statistical significance in the difference. The tests against polytetrafluoroethylene 
surfaces however suggested dependence in failure. In general, the larger the base of the 
microneedle, the higher the load it can endure before breaking or bending. Majority of the 
microneedles bend, and eventually tip off the glass when tested against 
polytetrafluoroethylene. The microneedles with larger base diameters break instead of 
bending at higher loads, which again confirms their greater mechanical stability. An 
alternative possibility in improving the mechanical property may be in introducing a 
microneedle post-bake processing step allowing the epoxy groups contained in the polymer 
to crosslink. Depending on the post-bake duration, the structures may become less elastic, 
and eventually brittle. 
Fracture and penetration study of microneedles with saw-toothed walls showed no 
significant differences in load response. A separate trial on piezoelectric actuation (in x, y, 
and z) over 80 μm range to mimic mosquito fascicle movement also showed no significant 
difference in load response when compared to no piezoelectric actuation.  In previous 
studies, hollow Ormocer® microneedles with large wall thicknesses fabricated by 2PP have 
shown a non-linear stress–strain response.142 These results suggest that 2PP may be 
employed to create medical microdevices with a larger range of sizes, shapes, and materials 
than conventional polymer, silicon, stainless steel, or titanium microfabrication techniques. 
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Figure 37. Optical micrograph of an off-centered microneedle on full-thickness porcine skin. 
The stratum corneum (SC), epidermis (E), and dermis (D), and fat (F) layers of the full-
thickness skin are indicated. Scale bar equals 150 μm. 
 
 
Figure 38. Load vs. Displacement results for microneedle arrays with varying tip sharpness. 
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 Controlled administration of fluorescein-conjugated biotin (a water-soluble B-
complex vitamin) into the dermal and hypodermal regions of skin was achieved using off-
centered microneedles. Figure 39 contains DIC-fluorescence micrographs of biotin-
administered skin sections (frozen at various times). The images containing the microneedle 
perforations showed penetration into the epidermal/dermal junction. At 60 minutes, the 
control of topically applied biotin showed no dispersion beyond the stratum corneum layer. 
However, administration of biotin via microneedles showed penetration well into the dermal 
layers of skin at 60 minutes. At 0-5 minutes, the biotin was localized in the perforation 
created by the microneedles. At 20 minutes, the diffusion of biotin into the dermal/epidermal 
junction was evident. At 60 minutes, the entire dosage of biotin diffused deep into the 
dermal/hypodermal region of the skin.  
 Controlled administration of 8 µM Qdot® 655 ITK™ amino (PEG) quantum dot 
solution into dermal layers was also achieved using off-centered microneedles. Figure 40 
contains DIC-fluorescence micrographs of QD-administered skin sections (frozen at various 
times). As with biotin at 60 minutes, the control of topically administered QD PEG-amine 
showed no dispersion beyond the stratum corneum layer. Previous studies by Ryman-
Rasmussen et al.143 have shown that topical administration of QD PEG-amine leads to 
localization in the dermal layer by 8 h. Administration of QD PEG-amine by microneedles 
showed no dispersion at 0-5 minutes. However, at 60 minutes, extensive dispersion of QD 
PEG-amine was observed within the epidermal and dermal layers of skin. In comparison with 
topical administration, the passive diffusion/delivery to dermal layers is much more rapid 
using microneedles.  These microneedles may also allow control over rate of dispersion and 
diffusion of pharmacologic agents into dermal layers by variation in the penetration depths.  
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Figure 39. DIC-fluorescence optical microscopy of skin after administration of fluorescein-
conjugated biotin using Ormocer® microneedles. Time of treatment with microneedle (5 min, 
20 min, and 60 min) is noted on top of each column and may be compared with control at 60 
min (without microneedle). Top row: DIC single-channel allows clear view of the various 
skin layers. The stratum corneum (SC), epidermis (E), and dermis (D) layers are indicated. 
Middle row: fluorescence scans (FL) of fluorescein-biotin emission. Bottom row: DIC-
fluorescence overlay (OVR) with the fluorescence channel (Green) shows distribution of 
biotin within the skin layers. Scale bar equals 100 μm. 
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Figure 40. DIC-fluorescence optical microscopy of skin after administration of PEG-amine 
(NH2)-coated quantum dot (QD 655) using Ormocer® microneedles. Time of treatment with 
microneedle (5 min and 60 min) is noted on top of each column and may be compared with 
control at 60 min (without microneedle). Top row: DIC single-channel allows clear view of 
the various skin layers. The stratum corneum (SC), epidermis (E), and dermis (D) layers are 
indicated. Bottom row: DIC-fluorescence overlay (OVR) with the QD-fluorescence 
channel (Red) shows distribution of QD within the skin layers. Scale bar equals 100 μm. 
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Microneedle arrays developed using conventional microelectronics fabrication 
techniques have inherent limitations that preclude the development of complex geometries 
and large microneedle wall thicknesses.144-148 CAD/CAM rapid prototyping  may allow 
fabrication of complex geometries with rapid iterations. Novel microneedles developed in 
this fashion may be integrated with MEMS devices to allow control over amount and rate of 
pharmacologic administration. The control over the geometry of the microneedle enables its 
application for both drug delivery and blood drawing. 
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3.1.5 Ossicular Replacement Prosthesis 
Ormocer® ossicular replacement prostheses were fabricated by two-photon 
polymerization process. The design used in this study was similar to that of a commercially 
available TORP prosthesis (Kurz Medical Inc., Dusslingen, Germany). Figure 41 contains a 
CAD and optical image of the TORP-shaped Ormocer® ossicular prostheses. The prostheses 
stand 4.3 mm tall, 300-400 μm wide at shaft, 2.6 mm wide and 400-500 μm thick at the disk-
shaped headplate. The disk-shaped headplate of the prosthesis was designed to be placed 
under the tympanic membrane. The shaft of the prosthesis was designed to connect the 
footplate of the stapes with the undersurface of the tympanic membrane in order to enable 
sound conduction. The headplate also contained five microneedle-like structures protruding 
at 400 μm with 160 μm base width. These structures were introduced to improve cellular 
adhesion, reduce device migration, and decrease the likelihood of perforation of the tympanic 
membrane. Figure 42 contains optical micrographs of Ormocer® TORP fabricated by 2PP 
using two different head-plate designs.  
Nanoindentation tests performed on the surface of the headplate of the ossicular 
prosthesis were compared with thin-film Ormocer® material (Figure 43). As the load 
increased, the measured values of Hardness (H) and Modulus (E) of the Ormocer® thin-film 
were found to be significantly higher than the headplate surface. Both values were 
consistently higher by a factor of four in the thin-film material. Figure 44 contains atomic 
force micrographs of the Ormocer® headplate surface. A wavy-surface can be observed over 
a scan range of 70 μm using topographic and LFM mode. 
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Figure 41. CAD images and optical micrograph of TORP-shaped ossicular replacement 
prosthesis. Scale bar equals 1 mm. 
 
 
Figure 42. Optical micrographs of total ossicular replacement prosthesis fabricated by two-
photon polymerization. Scale bar equals 1 mm. 
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Figure 43. Nanoindentation results of Ormocer® thin-film and ear-prosthesis. A: Graph of 
hardness (MPa) vs. indentation depth (mm) and B: graph of modulus (MPa) vs. indentation 
depth (mm). Symbols “¡” and “” represent values for Ormocer® thin-film and Ormocer® 
prosthesis, respectively. Bars in graph A and graph B indicate standard deviation of mean 
hardness and modulus values, respectively. 
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Figure 44. AFM topographic scan and LFM image of Ormocer® ossicular prosthesis surface. 
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A total ossicular replacement prosthesis fabricated using 2PP may be developed for 
patient-specific geometries in order: (a) sustain small angles between the stapes and the 
prosthesis, which is associated with piston-like movement; (b) position the prosthesis on the 
center of the footplate to minimize rotation; (c) suitably align the prosthesis with respect to 
the surrounding middle ear structures.149 The Ormocer® ossicular replacement prosthesis 
demonstrated greater flexibility than commercially available TORP prostheses. In addition, 
the shaft–disk interface was more flexible and moldable than that observed in conventional 
titanium implants. Certain components of the ossicular replacement prosthesis may benefit 
from increased flexibility. For example, bending of the disk-shaped headplate with respect to 
the shaft may provide more stable fixation of the implant with respect to the tympanic 
membrane.150 The implantation process through the right external auditory canal is shown in 
Figure 45. A tympanomeatal flap was raised before and was flapped back prior to the 
procedure. The prosthesis was positioned on the footplate of the stapes below the tympanic 
membrane to provide sound conduction, as found in natural middle ear. The prosthesis was 
handled without fracture during the entire procedure.  
Ormocer® ossicular replacement prosthesis has shown good mechanical properties, 
cytocompatibility, ease of forming and ease of handling. As mentioned earlier, conventional 
mass-produced implants do not sufficiently take individual patient anatomy into account. 
CAD/CAM rapid prototyping by 2PP may permit development of patient-specific geometries 
to allow unique fit with surrounding middle ear configurations and minimize prosthesis 
rotation and migration.  Imaging (computed tomography or magnetic resonance imaging) and 
analysis software may be employed to generate implants with appropriate design, structure, 
and material properties for a particular patient. 
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Figure 45. Implantation of Ormocer® ossicular replacement prosthesis into a commercially 
obtained un-frozen human head (right ear). A) View onto the incudo-stapedial joint. The 
chorda tympani has been partly removed. B) View onto the head of the stapes after the incus 
has been removed. C) View through external ear canal onto the eardrum. Ormocer® 
prosthesis lies against the posterior canal wall. D) Implant in situ with tympanomeatal flap 
raised anteriorly. Scale bar equals 2 mm. 
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3.2 MDW – MAPLE DIRECT WRITE 
In a conventional approach, matrix-assisted pulsed laser evaporation direct write or 
MDW utilizes a UV source light to evaporate the solvent to drive the solute or suspended 
particles forward to a receiving substrate.151 In depositing sensitive materials such as 
biomolecules and viable cells, the absorption coefficient of the solvent might not be entirely 
preclude absorption by the biomolecules. To by pass this, an intermediate absorbing layer 
was developed. Decomposing non-toxic polymers with high absorption coefficient near the 
UV-spectrum are thought to be promising. The ablation characteristics for various polymers 
have been studied earlier152 to determine the appropriate polymer for the required absorption 
coefficient and threshold fluence.  
 
3.2.1 Cell Micropatterning using TP Release Layer 
Triazene polymer (TP) has an effective absorption coefficient of the triazene polymer 
is calculated to be 49800±2900 cm-1 at a threshold fluence of 27±2 mJ/cm2 at 308 nm. At 248 
nm the threshold absorption coefficient is at a fluence range of 16 to 32 mJ/cm2. 153 The 
increase in transmission ratio with increasing wavelengths suggests lower transmission at 
193 nm wavelength. The thermal ablation of the polymer at UV results in release of N2 with 
a relevant bond energy in N=N of approximately 1.7 eV. The ablation parameters were 
calculated by the equation: d(F) = 1/αeff ln (F/Fth); where d(F) is the ablation rate 
(fluence/pulse), αeff is the effective absorption , and Fth the threshold ablation rate. 
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As a preliminary step in the study, the cytoompatibility of the triazene polymer 
material was investigated. Various cells including MG63 osteosarcoma, B35 neuroblast-like 
cells-like, and C2C12 myoblast-like cells were studied for adhesion, viability and growth on 
the triazene polymer substrate. Results demonstrated good adhesion and growth in 
comparison with polystyrene surface as control. Live-dead assays showed 100% viability in 
triazene surfaces. In the subsequent step, triazene coated ribbons were used for 
micropatterning viable cells onto substrates coated with ECM®.  
In order to study MDW micropatterning of B35 neuroblast-like cells, a capture device 
was setup and the process monitored for various laser fluence. The threshold fluence Fth for 
the process was found to be approximately 0.025 J/cm2. Various cell-patterns were generated 
using different input designs. Figure 46 contains optical micrographs of the ribbon used in 
micropatterning B35 neuroblast-like cells with and without the triazene polymer release 
layer. The arrows shown in Figure 46A indicate laser ablated region of the TP release layer 
(similar to circular laser spot-size). The cells were transferred to the substrate from the ribbon 
in a well defined pattern by controlled ablation of the TP layer. The remaining cells on the 
TP layer were observed to grow around the ablated regions. 
Figure 47 contains micrographs of live/dead stained cells in the TP layer on the 
ribbon. The laser spot size was reduced for subsequent rows (from top right) as seen in 
Figure 47A. Figure 47B contains fluorescent image of the live/dead stained B35 neuroblast-
like cells on the TP layer on ribbon. Green fluorescing viable cells can be observed. in the 
non-ablated regions and in ablated areas where the overlap is poor due to smaller laser spot 
size. The laser-ablated TP region was found to be approximately the size of an individual 
B35 neuroblast-like cell. Such control over individual cells may prove to be beneficial. 
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Figure 46. Optical micrographs of the ribbon used for MDW micropatterning of B35 
neuroblast-like cells A) with triazene polymer release layer (scale bar equals 20 μm) and B) 
without any release layer (scale bar equals 100 μm). Arrows indicate circular ablated regions 
of the polymer. Images were recorded at 48 h post micropatterning. 
 
 
Figure 47. A) Optical and B) fluorescent live/dead micrographs of the ribbon with triazene-
polymer release layer for MDW micropatterning of B35 neuroblast-like cells. Images were 
recorded 48 h post micropatterning. Scale bar equals 20 μm. 
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Figure 48A contains an optical micrograph of B35 neuroblast-like cells 
micropatterned into a box-like design. The boundaries were fairly well-defined, considering 
cell locomotion post micropatterning. In another pattern (Figure 48B), line width of 
approximately 100 μm was achieved. Figure 49 contains optical micrographs of B35 
neuroblast-like cells at 6 h and 48 h post micropatterning. At 3-6 h the substrate contains few 
neuroblasts cells at the initial stage of growth with short axons. At 24-48 h, there is a 
significantly higher cell-density with longer axonal extensions, suggesting viability and 
proliferation post patterning. The optical micrographs at selective time points were compared 
to determine the growth rate based on the average number of cells per unit area. The growth 
rate of the B35 neuroblast-like cells micropatterned via MDW using the triazene absorbing 
layer was statistically similar to the growth rate of as-seeded cells. No preferential growth 
was observed. 
Confocal images of stained nuclei and cytoskeleton of MDW cells were also 
compared at various time intervals. Figure 50contains confocal images at 24 h and 48 h post 
micropatterning. At 12-24 h the nuclei of the micropatterned cells appear intact and the 
development of axons cannot be clearly determined. The cells at 24-48 h post 
micropatterning show preservation of nuclei and some well developed axonal extensions. 
The current approach using triazene polymer as a release layer demonstrates successful 
micropatternings at threshold fluence of approximately 0.025 J/cm2, while previous efforts 
were achieved at higher fluence of 0.07 to 0.1 J/cm2. This is particularly significant in the 
micropatterning of viable cells and soft biomolecules. These results demonstrate that the 
MDW technique is competent in creating micropatterns of viable cells at low laser fluence. 
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Figure 48. Optical micrograph of B35 neuroblast-like cells micropatterned into A) box-like 
design (scale bar equals 100 μm) and B) line pattern (scale bar equals 20 μm). Arrows are 
drawn to guide the eye. 
 
 
Figure 49. Optical micrograph of B35 neuroblast-like cells at A) 6 h and B) 48 h post 
micropatterning. Scale bar equals 20 μm. 
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Figure 50. Confocal micrograph of B35 neuroblast-like cells shows viable nucleus and 
cytoskeleton at A) 24 h and B) 48 h post micropatterning. Scale bar equals 10 μm. 
 
 
 
 
 
 
 
 
 
 
 
98 
3.2.2 Microfabrication of Bioceramics 
The MDW process was also employed to develop microstructures of bioceramics 
such as hydroxyapatite, zirconia, and viable mammalian osteosarcoma cells. Figure 51 
contains optical micrograph of the ribbon and substrates employed in developing 
micropatterns of hydroxyapatite. Ablated regions lacking the HA coating can be observed in 
the ribbon (Figure 51A). Discrete points, lines, and squares can be observed in the substrate 
(Figure 51C-D). These mesoscopic patterns maintain the dimensions and boundaries seen in 
the ribbon. The MDW process also maintained the composition and phase of the target 
material. Figure 52, an X-ray diffraction pattern of hydroxyapatite after laser interaction 
reveals the (200), (111), (002), (102), (210), (211), (112), (300), (202), (310), (222), (320), 
(213), (004), and (304) peaks of crystalline hydroxyapatite (Figure 53).154, 155 
Scanning electron micrographs (Figure 54) reveal the microstructure of 
hydroxyapatite. A porous mesh-like network is observed at various magnifications. The 
porosity of MDW-transferred hydroxyapatite may be tailored to in vivo application by 
controlling the size of the ceramic powder, the amount of solvent used to prepare the ribbon, 
and the choice of solvent used to prepare the ribbon. Figure 55 contains optical micrograph 
of hydroxyapatite line micropatterned by MDW on borosilicate glass substrate. Label “A” 
indicates the hydroxyapatite thin film, “B” indicates the borosilicate glass substrate. “C” and 
“D” indicate micrometer-sized particles, which result from splashing of material during the 
MDW process. From the scanning electron micrograph (Figure 56) several features can be 
observed. Region “A” indicates the location of the porous hydroxyapatite thin film, “B” 
indicates the location of the borosilicate glass substrate, and “C” indicates the location of 
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micrometer-sized particles, which result from splashing of material during the MDW 
process.  
Figure 57 contains optical images of zirconia micropatterns developed by MDW. A 
square-edged pattern of zirconia was developed, with a relatively well-defined boundary. 
Scanning electron micrographs (Figure 58) reveal discrete pebble-like particles with size-
distribution of 0.3 to 2 μm. Splashing near the boundary was also observed, and this occurs 
during the transfer process and may be eliminated using a micromachining technique. 
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Figure 51. (A) Optical micrograph of MDW ribbon coated with hydroxyapatite. 
Ablated regions can be observed. (B-D) Optical micrographs of hydroxyapatite patterns on 
borosilicate glass substrates.  
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Figure 52. X-ray diffraction of hydroxyapatite after MDW processing. Various peaks that 
correspond to crystalline hydroxyapatite are labeled. 
 
 
Figure 53. Representative diagram of the structure of crystalline hydroxyapatite with various 
peaks.21 
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Figure 54. Scanning electron micrographs of hydroxyapatite micropatterned by MDW, at 
several magnifications. 
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Figure 55. Optical micrograph of hydroxyapatite line micropatterned by MDW on 
borosilicate glass substrate. “A” indicates the hydroxyapatite thin film, “B” indicates the 
borosilicate glass substrate. “C” and “D” indicate micrometer-sized particles.                         
Scale bar equals 50 μm. 
 
 
Figure 56. Scanning electron micrograph of hydroxyapatite. “A” indicates the location of the 
porous hydroxyapatite thin film, “B” indicates the location of the borosilicate glass substrate, 
and “C” indicates splashing of material during the MDW process. Scale bar equals 10 μm. 
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Figure 57. Optical micrographs of zirconia micropatterned by MDW. 
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Figure 58. Scanning electron micrographs of zirconia micropatterned by MDW, at 
several magnifications. 
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3.2.3 Microfabrication of Osteoblast-bioceramic composite 
Hydroxyapatite [Ca10(PO4)6(OH)2] is a bioactive ceramic that forms chemical bonds 
with bony tissues. Recent studies have shown that osteoblast cells attach, proliferate, and 
differentiate on hydroxyapatite surfaces.156, 157 These cells secrete osteoid (proteoglycans, 
glycoproteins, type I collagen), enzymes (osteocalcin and alkaline phosphatase), and growth 
factors (interleukin-1) that mediate in vivo bone growth. Hydroxyapatite also exhibits 
controlled in vivo degradation rates, which are dependent on phase, surface area, 
crystallinity, and ionic substitution.158, 159 In addition, hydroxyapatite acts as a source for 
calcium, phosphorus, sodium, and magnesium ions necessary for in vivo bone growth. 
Scaffolds using zirconia, an inert ceramic that exhibits a stable oxide surface, high hardness, 
high corrosion resistance, and high wear resistance were also developed.160 
Reproducible control over microstructure and surface characteristics may provide 
unique biological functionalities at the tissue/implant interface. For example, osteoblast 
proliferation, osteoblast differentiation, angiogenesis, and other processes can be modulated 
by surface roughness.161 Boyan et al.162 have shown that MG63 cells respond to increasing 
surface roughness with increased differentiation and decreased proliferation. Several markers 
and mediators of cell activity, including alkaline phosphatase, osteocalcin, TGF-β1, and 
prostaglandin E2, are produced in greater amounts on rougher surfaces.  In addition, MG63 
cells exhibit enhanced responsiveness to hormones (e.g., 1,25-(OH)2D3) on rougher surfaces. 
In addition, Brauker et al.163 have shown that materials with pores with sizes between 0.8 
μm-8 μm exhibit increased amounts of cell penetration and neovascularization (blood vessel 
formation). The interaction among several MDW process parameters, including the laser 
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fluence, laser spot size, ceramic powder size, ribbon-substrate length, amount of solvent used 
to prepare the ribbon, and choice of solvent used to prepare the ribbon, may provide 
additional opportunities to create unique surface morphologies and improved tissue/implant 
interfaces.164 
Figure 59 contains optical micrographs of the ribbon and substrate used in the MDW 
co-deposition of MG63 osteosarcoma cells and hydroxyapatite. Ablated regions within the 
square-design used for the process can be observed on the ribbon. Figure 60 contains optical 
micrographs of the substrate containing the MG63 cells and hydroxyapatite particles. The 
osteosarcoma cells exhibits cytoplasmic extensions in the presence of the hydroxyapatite 
matrix. Optical micrographs at 3 hours and 96 hours post deposition show increased growth 
and proliferation of the cells. The cell-density increased significantly and the cells appear to 
bond with the hydroxyapatite matrix. Figure 61 compares the growth profile of MG63 
osteosarcoma under there different conditions: 1) as-seeded without MDW process,  2) 
deposited by MDW process, and 3) co-deposited with HA by MDW process. The growth 
profile of the cells in the three cases was found to be statistically identical. No preferential 
growth was found during the various time intervals (3, 6, 12, 24, 48, 72, and 96 h).  
Figure 62 contains the live/dead fluorescent images of the osteosarcoma cells 48 
hours after deposition by MDW. Viable MG63 cells from an MDW square-pattern can be 
observed in Figure 62 A-B. The osteosarcoma cells exhibit growth and proliferation after 
deposition. Results from live/dead analysis suggested that nearly 100% of the cells remained 
viable after the process. Figure 63 contains the live/dead stained images of osteosarcoma 
cells 72 hours after co-deposition with HA. Arrow indicate confluent osteoblast-like cell 
surrounded by hydroxyapatite matrix. 
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Figure 59. Optical micrograph of the ribbon used for MDW co-deposition of MG63-
osteosarcoma cells and hydroxyapatite. Ablated regions can be clearly observed.                               
Scale bar equals 100 μm.  
 
 
Figure 60. Optical micrograph of the substrate containing MG63-osteosarcoma cells and 
hydroxyapatite co-deposited by MDW. Images were taken (A) 3 hours and (B) 96 hours post 
deposition. Scale bar equals 20 μm.  
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Figure 61. Growth profile of MG63 osteosarcoma cells: (1) as-seeded condition, 2) 
deposited by MDW process, and 3) co-deposited with HA by MDW process. Values are 
expressed as mean ± standard deviation.  
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Figure 62. Live/dead stained A) optical and B) fluorescent micrographs of MG63 
osteosarcoma cells 48 h after MDW deposition. Scale bar equals 20 μm. 
 
 
 
Figure 63. Live/dead stained A) optical and B) fluorescent micrographs of MG63 
osteosarcoma cells 72 h after MDW co-deposition with HA. Scale bar equals 20 μm. 
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Previous studies on MDW have also successfully demonstrated micropatterning of 
several cell types, including C2C12 myoblast-like cells and B35 neuroblast-like cells. Cells 
have shown ~ 100% viability.165, 166 Cytotoxicity and mutagenicity studies have confirmed 
lack of evidence of DNA strand breakage in cells.167-169 MDW is a versatile technique for 
creating multilayer, heterogeneous structures that may be developed as tissue scaffolds. The 
ability to microfabricate cell-ceramic composites offers structural integrity in using two-
dimensional layers to build mechanically robust three dimensional heterogeneous constructs.  
CAD/CAM co-deposition of osteosarcoma cells and hydroxyapatite may exploit  
advantage of osteoconductive properties of bioactive ceramics. These findings on depositing 
mesoscopic patterns of cells, ceramics, and extracellular matrix composites that possess 
controlled microstructures may allow the development of novel dental and orthopaedic tissue 
substitutes. Based on the functionality and structural requirements, this concept can also be 
extended to integrate a variety of cell-lines with most organic/inorganic materials. Integration 
of viable cells and biomaterials prior to tissue fabrication may allow significant advantages 
including adequate cell penetration and control over cell-density through the scaffold.   
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3.3 CLM – CAD/CAM Laser Micromachining 
CAD/CAM laser micromachining provides a direct-write approach similar to MDW 
for microfabrication of biomaterials. Unlike MDW, CLM utilizes a high laser power to 
selectively ablate biomaterials. Microstructures and biointerfaces developed by CLM may be 
utilized as surface recognition regions for differential adherence and selective cellular growth 
to tissue networks. In this section, the development of CLM as a rapid prototyping tool for 
biomedical applications is described.  
 
3.3.1 Silicon Micromachining  
CAD/CAM laser micromachining was developed for controlled direct-write 
microfabrication of biomaterials. As described earlier, laser interaction with materials depend 
on the various properties of the material and source light. At the early stage of development, 
polished silicon substrates were chosen to allow understanding of the laser interaction with 
material. Silicon substrates are the ‘gold-standard’ in the microelectronic arena. Microscale 
integration of biological agents to silicon substrates may also allow advancement in the bio-
sensor/electronics field.   
 CLM of silicon was studied in a systematic approach of varying a single process 
parameter while keeping the rest constant. In the first step, the aperture was varied to allow 
control over the laser-spot size. Simple line/channel patterns (with repetition of two) were 
developed for each aperture. The laser output energy from the tube was kept constant at 
186mJ±6mJ using the voltage control at 25V. Figure 64 contains optical micrographs of 
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ablated regions of Si after CLM processing at various apertures (1-7). The cross-sectional 
view (Figure 64B) illustrates the depth of ablation. An increase in aperture size causes an 
increase in depth of ablation. The ablation was noted to be U-shaped for each aperture. The 
laser spot has a Gaussian spread of energy-density and wavelength, with the peaks 
approximately in the center of the spot. The Gaussian spread would produce a non-linear 
ablation at the site of interaction, with peak interactions in the middle, which may explain the 
U-shaped cut. From the top-view (Figure 64B), it can be observed that an increase in aperture 
size also causes an increase in the width of ablation (dark regions). Additionally, 
splashing/sputtering of debris around the ablated channels was significantly higher for larger 
apertures. Evidently, larger apertures would allow more photons to interact with the material. 
An increase in laser-material interactions would develop deeper, wider ablations with more 
splashing. Figure 65 contains a graph illustrating the ablation width and depth of Si (111) 
during CLM with increasing apertures. A linear increase in depth of ablation was noted by a 
linear increase in width, for increasing aperture sizes.  
In the next step, the laser energy density was systematically varied to allow control 
over intensity of photons in material interaction. Simple line/channel patterns (with repetition 
of two) were developed for each trial. The aperture controlling the spot-size was kept 
constant. Figure 66 contains optical micrographs of ablated regions of Si after CLM 
processing at various energies (controlled by voltage setting). The approximate energy output 
corresponding to a given voltage setting was as follows: 21V-60 mJ, 22V-96 mJ, 23V-135 
mJ, 24V-162 mJ, 25V-186 mJ, 26V-213 mJ, and 27V-225mJ. The tolerance on all energy 
levels was less than 5%. The cross-sectional view (Figure 66A) illustrates the depth of 
ablation and the top-view of CLM processed silicon (Figure 66B) illustrates the width of 
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ablation for a systematic increase in laser energy density. As previously, splashing/sputtering 
of debris around the ablated channels was significantly higher for larger energy density. 
Evidently, larger energy densities allow more photons to interact with the material leading to 
the ablation results observed. Figure 67 contains a graph illustrating the ablation width and 
depth of Si (111) during CLM with increasing laser energy density.  
Finally, CLM was investigated for line/channel patterns with increasing repetitions 
(1x, 2x, 4x, 8x, 16x) to confirm linearity in laser-material interactions. The laser output 
energy from the tube was kept constant at 186mJ±6mJ using the voltage control at 25V. The 
aperture controlling the spot-size was also kept constant. Figure 68 contains optical 
micrographs of ablated regions of Si after CLM processing using various repetitions 
(increased exponentially). The depth of ablation increases dramatically to sharper trenches 
and from a U-shaped cut to a V-shaped cut (Figure 68A). A repetitive ablation would allow 
an additive Gaussian shift each time the material is ablated. Over additional interactions, the 
central peak region of the laser spot would have a larger increase in number of photons than 
that of the periphery, which would explain the non-linear transformation. The width of the 
channels (Figure 68B) appears to be constant for all the repetition trials. This was anticipated 
as the aperture size or energy density was not varied. Splashing/sputtering of debris around 
the ablated channels was significantly higher owing to increased laser interaction within the 
localized region. Figure 69 contains a graph illustrating the ablation width and depth of Si 
(111) during CLM with increased interaction times by varying repetitions. As estimated, 
there was no significant change on the width of ablation. The depth of ablation increased 
exponentially with an exponential increase in repetition times. Thus, the increase in depth of 
ablation was found to be linear with increasing interaction times/repetitions.  
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Figure 64. Optical micrograph of Si (111) in A) cross-sectional view and B) top-view after 
CLM as a function of aperture. Scale bar equals 200 μm. 
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Figure 65. Graph of ablation width and depth on Si (111) as a function of aperture and laser 
spot size. Data is expressed as mean ± standard deviation. (P<0.05) 
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Figure 66. Optical micrograph of Si (111) in A) cross-sectional view and B) top-view after 
CLM as a function of laser energy (shown for control voltage). Scale bar equals 200 μm 
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Figure 67. Graph of ablation width and depth on Si (111) as a function of laser energy 
(control in Volts) at constant aperture and repetition. Data is expressed as mean ± standard 
deviation. (P<0.05) 
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Figure 68. Optical micrograph of Si (111) in A) cross-sectional view and B) top-view after 
CLM as a function of pattern repetition or overlap. Scale bar equals 200 μm. 
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Figure 69. Graph of ablation width and depth on Si (111) as a function of repetition (1x, 2x, 
4x, 8x, and 16x) at constant aperture size. Data is expressed as mean ± standard deviation. 
(P<0.05) 
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Figure 70 contains a scanning electron micrograph of CLM processed Si (111) in a 
20x20 dot-array pattern. The energy density and aperture was systematically lowered to 
investigate minimum ablation feature that may be obtained from the CLM setup. Figure 71 
contains additional SEM images. Ablations width of approximately 5 μm was observed 
(Figure 71A) which was also near the theoretical limit for the 10x UV objective. Control over 
spot-size may be achieved by the aperture shape. An elliptical ablation (~ 40x20 μm) may 
also be obtained (Figure 71B).  
CLM of silicon was also used to develop various groove-like patterns to observe the 
growth and orientation of human aortic vascular smooth muscle cells (HA-VSMC). Figure 
72 contains optical micrographs at 48 h for HA-VSMC on silicon. The cells grow in the non-
ablated regions within the micromachined grooves and form contact points with the two 
ends. Figure 72B illustrates the perpendicular alignment with the cells stretching out on both 
ends. Figure 72C illustrates random orientation of cells in plain silicon substrate.  
CLM processing of silicon was used to understand laser interaction of material. It also 
allowed means to investigate and integrate the various process parameters. CLM may allow 
controlled alignment of cells and integration possibilities for bioelectronic applications. 
Differential growth was observed in the non-ablated regions. However, CLM of silicon may 
not be an ideal candidate of interfaces to develop tissue constructs owing to a various reasons 
including ablation splashing and microparticles that may influence cell-growth, hydrophobic 
nature allowing non-preferential growth of cells, rigidity, non-biodegradable, and time 
required for processing. Hence, a hydrophilic material that may address these concerns was 
pursued as an interface for developing tissue networks.  
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Figure 70. Scanning electron micrograph of a 20x20 micromachined dot array in Si (111) 
developed by controlled aperture and laser energy density. Scale bar equals 1 mm. 
 
 
Figure 71. Scanning electron micrograph of CLM processed Si (111). A) 5 mm circular 
ablation, and B and C) various magnification of an elliptical ablation.  
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Figure 72. HA-VSMC (human aortic – vascular smooth muscle cells) on A & B) laser 
micromachined Si grooves at different magnifications and on C) plain silicon surface as 
control. Images were recorded 48 h post seeding. Scale bar equals 100 μm. 
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3.3.2 Hydrogel Micromachining  
Hydrogels such as agarose gel were thought to be promising candidates as 
biointerfaces for development of tissue constructs. Owing to the hydrophilic nature of the 
material, most cell-types would not adhere to the surface. Microfabrication of such materials 
with growth factors may allow development of differential adherent surfaces to develop 
novel tissue constructs.  
The ablation characteristics of agarose during laser micromachining were examined 
as a function of laser energy density and as a function of aperture (or laser spot size). 1% 
agarose gels were micromachined using a constant laser spot size (D) of ~250 μm,  repetition 
rate (R) of 10 Hz, and constant feed rate (F) of 500 μm/s, which allowed for approximately 
20% overlap of spots. Figure 73 contains images of cross-sectional and top-view of agarose 
gel which were prepared by CLM at several energy densities. The laser energy density values 
of 1.0 -2.2 J/cm2 in 0.2 J/cm2 increments were used. Figure 74 contains a corresponding 
graph illustrating the mean ablation width and depth of the gel at various laser energy 
densities. This data suggested that the ablation depth increased linearlyas the laser energy 
density was increased. The ablation width remained relatively constant and did not show a 
significant increase in the 1-2 J/cm2 energy density range (p<0.05). However, a sharp non-
linear increase was observed at higher laser energy density values (e.g., 2.2 J/cm2), which 
may be attributed to non-linear laser-biomaterial interaction. 
Figure 75 contains an optical micrograph of laser-micromachined agarose channels 
that were prepared using varying apertures (or laser spot sizes). Approximate spot-sizes of 
the aperture settings were as follows: Labels 1: 150 μm, 2: 600 μm, and 3: 1000 μm. Figure 
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76 shows a graph illustrating the mean ablation width and depth of agarose hydrogel for 
various aperture sizes. The ablation width increased with aperture size, which was noted to 
be within standard deviations of the laser spot size. The ablation depth also increased linearly 
with laser spot size. The standard deviation increased with the aperture size. Figure 76 also 
demonstrated that it was possible to obtain magnitude of difference in ablation dimensions 
(from approximately 200 μm to 1100 μm) by varying aperture size and laser intensity. 
As described earlier, laser spot size (D) may be varied by changing the size of the 
aperture on the laser path to the objective. For each spot size D, the feed rate F was 
calculated by F = (0.2).D.R μm/s, which allowed for 20 % overlap. The feed-rate of the 
translation axes is an important parameter that determines the extent of overlap between 
subsequent laser pulses at a given laser spot size and repetition rate. The overlap defines the 
roughness of the undercut (rough schematic shown in Figure 77). For laser micromachining 
of agarose gels, minimal roughness was obtained at approximately 20% overlap. Greater than 
50% overlap resulted in deep trenches toward the channel center, and less than 10% overlap 
resulted in small ripple structures along the channel. An understanding of the ablation 
characteristics of agarose and other scaffold materials is critical for obtaining appropriate 
geometries for CAD/CAM microfabrication of tissues. 
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Figure 73. Optical micrograph of 1% agarose hydrogel in A) cross-sectional view and B) 
top-view after CLM as a function of laser fluence (indicated on top row above each 
channel). Scale bar equals 500 μm. 
 
0
50
100
150
200
250
300
350
400
450
1 1.2 1.4 1.6 1.8 2 2.2
Laser Energy Density (J/cm2)
A
bl
at
io
n 
W
id
th
, D
ep
th
 (M
ic
ro
ns
) Width
Depth
 
Figure 74. Graph of ablation width and depth of 1% agarose gel as a function of laser energy 
density at constant aperture and repetition. Data is expressed as mean ± standard deviation. 
(P<0.05) 
 
124 
 
 
Figure 75. Optical micrograph of 1% agarose hydrogel in cross-sectional view after CLM as 
a function of aperture. Scale bar equals 500 μm. 
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Figure 76. Graph of ablation width and depth of 1% agarose gel as a function of aperture 
(and laser spot size). Data is expressed as mean ± standard deviation. (P<0.05) 
 
125 
 
 
Figure 77. Schematic showing the relationship between feed-rate (F), diameter of spot-size 
(D) and repetition rate (R) in various overlap scenarios. 
 
 
 
Figure 78. Optical micrograph of 1% agarose channels with reservoirs developed by CLM. 
Scale bar equals 2 mm. 
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3.3.3 CLM Development of Cellular Networks 
An understanding of ablation characteristics of agarose hydrogel was critical in 
developing CAD/CAM patterns. Process control was achieved by utilizing the ablation 
characteristics for the material and integrating with the CAD module and laser/stage-
translation parameters. In order to investigate differential adherence of cells and development 
of CAD/CAM tissue networks, various designs were sought. Channels with varying widths 
were thought to provide insight into preferential adherence and alignment. Each channel and 
circle design was provided with a reservoir to allow flow of growth factors and other 
required agents to facilitate cell growth. Figure 78 contains an optical micrograph of the 
CLM processed agarose hydrogels in channel/lines and circular patterns (widths of 60 – 400 
μm). Additional images of microfabricated designs using CLM are shown in Figure 79 and 
80.  
Microfabricated channels may be employed as biointerfaces or surface recognition 
regions for differential adherence and selective cellular growth to engineer cell-ECM 
networks. Extracellular matrix (ECM) proteins are known to induce cellular adhesion, 
growth and proliferation.170 Application of ECM within these microchannels may allow 
controlled alignment of cells. Reservoirs were fabricated adjacent to the channel, and were 
used to micropipette ECM® proteins into the channels. The undercut of the channel allowed 
uniform flow of extracellular matrix liquid within the channel. These microfabricated 
growth-factor filled channels were developed in 6-well plates for cell-growth studies using 
B35 rat neuroblast-like cells, A431 human epithelial carcinoma cells and C2C12 mouse 
myoblast-like cells.  
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Figure 79. Optical micrograph of a 3D perspective view of micromachined agarose channels 
(M) and (C) with reservoirs (R). Scale bar equals 500 μm. 
 
 
Figure 80. Optical micrograph of CLM processed agarose channels with reservoirs on 6-well 
plates. Scale bar equals 1 cm. 
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Figure 81 contains the initial coverage, migration, proliferation and growth of B35 
neuroblast-like cells in ECM® growth-factor filled 60 μm agarose channels.  Upon the initial 
addition, less than 20% of the cells contacted the ECM. This ensured that the adhered cells 
would form non-confluent surfaces within the channels and their interactions with 
neighboring cells could be easily observed. The cells later migrated with increasing coverage 
across the channel length over time. With continued growth and proliferation the cells in 
channels aligned parallel to the channel length to form the most packed alignment within the 
channel. This phenomenon was particularly evident in C2C12 myoblast-like cells where 
channel width was lower than 150 μm. Previous studies have shown that cells will physically 
respond to micron-sized features; specifically, cells will align themselves to the groove and 
become elongated in the direction of the groove.171, 172  
Figure 81 (a) shows the cells in a trypsinized state and Figure 81 (b) shows the initial 
coverage of approximately 20%. At longer time-intervals, the cells near the wall were 
observed to orient themselves along the length of the channel. At 48-72 hours the cells were 
observed to be multinucleated with a significant change in phenotype, indicating matrix 
induced differentiation. Figures 82 A and B contains optical micrographs of 60 μm and 150 
μm channel with confluent B35 neuroblast-like cells. The images recorded at 72 hours post 
seeding, show supplemental growth with a high cell-density. There was also an increase in 
the average number of nuclei over time, suggesting differentiation of some neuroblast-like 
cells to multinucleated neuron-like cells. Figure 83 contains live/dead micrographs of a 60 
μm channel with B35 neuroblast-like cells. Green fluorescing nuclei in these live-dead 
stained cells showed viability of the cell with no damage to the nucleus.  
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Figure 81. Optical micrograph of growth and proliferation of B35 neuroblast-like cells on 
ECM filled micromachined channels. Images recorded at a) 10-15 min, b) 6-9 h, c) 12-24 h, 
d) 24-48 h, e) 48-72 h, and f) 48-72 h near the reservoir end.                                                   
Scale bar equals 20 μm. 
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Figure 82. Optical micrographs of confluent B35 neuroblast-like cells in channels of width 
a) 60 μm and b) 150 μm; recorded 72 hours post seeding. Scale bar equals 50 μm. 
 
 
 
Figure 83. A) Optical light and B) fluorescent micrograph of a 60 μm channel containing 
B35 rat neuroblast-like cells stained with live/dead assay.  Scale bar equals 20 μm. 
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Figure 84 contains live/dead micrographs of a 100 μm channel with C2C12 mouse 
myoblast-like cells (adapted from Patz et al.39). The images recorded at 24 hours after 
seeding, demonstrate cells aligned parallel to the channel length. Green fluorescing nuclei in 
these live-dead stained cells indicated viability of the cell with no damage to the nucleus. The 
width of the C2C12 myoblast-like cell-network was observed uniform through the length. 
Figure 85 contains live/dead micrographs of a 60 μm channel with A431 human skin 
carcinoma cells. These squamous cells are flat and irregular, and renew basally. From Figure 
85A a higher cell density near the upper end can be observed. This may be attributed to basal 
renewal of these cells. The green fluorescing nuclei in these cells observed from Figure 85B 
demonstrated good viability with no signs of apoptosis.  
Further at 96 hours and longer, B35 neuroblast-like cell-matrix network began to 
delaminate from the agarose gel substrate. For the 1 cm long 100 mm channel, the aspect 
ratio for the fully grown network is approximately 100:1. This aspect ratio is preserved even 
after delamination. Figure 86 contains a fluorescent micrograph of a free-standing 100 μm 
wide cell-matrix-protein network suspended in growth media. This cellular network was 
obtained after 96 hours by delaminating from the microfabricated agarose channels. The 
micrograph also shows the neuron-like network curled up at one end with regions slightly out 
of focus. Also, the alignment and packing of cells within the microfabricated channels may 
evidently dependent on the shape, growth rate, signaling, and locomotion of cell. 
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Figure 84. A) Optical light and B) fluorescent micrograph of a 100 μm channel containing 
C2C12 mouse myoblast-like cells stained with live/dead assay.39  Images recorded 24 hours 
post seeding. Scale bar equals 250 μm. 
  
 
Figure 85. A) Optical light and B) fluorescent micrograph of a 60 μm channel containing 
A431 human skin epithelial carcinoma cells stained with live/dead assay. Images recorded 24 
hours post seeding. Scale bar equals 20 μm.  
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Figure 86. Optical fluorescence micrograph of a free-standing 100 μm wide neuron-like 
network suspended in a growth media. Image was recorded after delamination from 
micromachined channel. Scale bar equals 100 μm. 
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3.3.4 VEGF/Heparin-promoted CLM Development of Vascular Networks 
From the last section, the CLM process was successfully validated for 
microfabrication of a variety of cellular networks. Development of CLM for multi-cellular 
tissue networks using selective growth factors may prove to be further valuable to the field of 
regenerative medicine.  
Figure 87 contains a schematic of the various layers in human arteries and veins. 173 
As seen earlier, the artery contains various layers of different thicknesses. The inner sheet is 
tunica intima containing a thin layer of aortic endothelial cells. The subsequent layer contains 
a thin sheet of human elastin. This is followed by a thick layer of tunica media containing 
aortic smooth muscle cells. Subsequent layers of tunica externa contain connective tissue and 
epithelial cells. In order to allow development of multi-layered vascular networks, various 
designs were sought. Concentric circular rings with varying thicknesses connected to 
independent reservoirs were thought to be promising. Such a design may allow microfluidic 
flow of selective growth factors into each ring (representing each layer). As demonstrated 
earlier, CLM may allow microscale control over thickness and depth.  
Figure 88 contains optical and scanning electron micrograph of a two-circle ring with 
a 2x2 mm reservoir micromachined on Si (111) for validation. The outer ring was 4 mm in 
diameter and the inner ring was 3.5 mm in diameter. The ring thickness for both was 
approximately 250 μm. Figure 88B shows the channel from the reservoir connecting to the 
two rings without overlap to allow controlled microfluidic flow. The micropositioning feed-
rate and laser parameters were fine-tuned to obtain ablations within 5% tolerance of the 
original design. Figure 89 contains images from the various stages of CLM development. 
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Figure 89A shows the initial design validation from the translation stage after CAD input. 
Figure 89B shows validation of design from CLM of Si (111). Figure 89C shows 
development of a similar design on agarose hydrogel. Figure 89D shows confluent aortic 
cell-growth on the CLM microfabricated design filled with Matrigel® growth factors.  
These results were used to develop two/three layered ring networks in agarose gels 
with the inner layer containing human aortic endothelial cells, the middle layer containing 
human elastin, and the outer layer containing human aortic vascular smooth muscle cells.  In 
order to develop a differential adherent surface for the two aortic cells (human aortic 
endothelial cells and human aortic smooth muscle cells) various growth factors were sought. 
There are various angiogenic factors that are responsible for neovascularization and 
growth/proliferation/inhibition of vascular cells. Some of these factors include fibroblast 
growth factors (FGF), platelet-derived endothelial cell growth factor (PDGF), transforming 
growth factors (TGF α &,β), angiogens, TNF-α , IL-8, VEGF, heparin and many other still 
researched.174-176 Among them, vascular endothelial growth factor (VEGF) is widely noted 
for its role on the stimulated growth and proliferation of aortic endothelial cells. 
Transplantation results with heart cells have shown increased VEGF expression.177 Other 
studies have shown heparin as a non-selective agent inhibiting growth of aortic smooth 
muscle cells.178, 179 Weatherford et al.180 have shown VEGF-promoted proliferation of 
endothelial cells and inhibition of smooth muscle cells. Exploiting these phenomena in a 
microfabricated interface may allow great potential for development of tissue constructs. 
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Figure 87. Schematic of the various layers present in a human vasculature.173 
 
 
Figure 88. A) Optical micrograph of a two-circle ring design and B) scanning electron 
micrograph at the channel/ring interface. Scale bar equals 400 μm. 
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Figure 89. The various stages of CLM development from a CAD design input to 
microfabricated cellular network output. Image of A) CAD design, B) CLM of Si (111), C) 
CLM of agarose gel, and D) HAAE-1 human aortic endothelial cells on CLM 
microfabricated agarose/matrix-protein gel. Scale bar equals ~ 1 mm. 
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Vascular endothelial growth factor (VEGF) and heparin were selected to develop 
differential adherent interfaces for the two types of aortic cells. VEGF in concentrations of 1, 
10, 100, 1000 ng/ml and heparin in 1, 10, 100, 1000 units/ml were used to study the 
cytocompatibility and growth/proliferation of HAAE-1 human aortic endothelial cells and 
HA-VSMC human aortic smooth muscle cells. The MTT viability data is first analyzed 
between various concentrations for each cell-type. The viability is then analyzed between the 
two cell-types at each concentration.  
Figure 90 contains graph illustrating the viability of cells with increasing amounts of 
VEGF (1 to 1000 ng/ml). MTT viability assay suggested that increasing amounts of VEGF 
reduces viability of HAAE-1 and HA-VSMC cells, in comparison with regular media. 
Viability of both cells were significantly higher at V1 (VEGF: 1 ng/ml) than at V10 (VEGF: 
10 ng/ml), V100 (VEGF: 100 ng/ml) or V1000 (VEGF: 1000 ng/ml) (p<0.05). There was no 
significant difference observed in the viability of the cells for V10, V100 or V1000. When 
comparing the two cell-types, the viability of HAAE-1 was significantly higher than that of 
HA-VSMC at all VEGF concentrations. This suggested VEGF-induced proliferation of 
HAAE-1 human aortic endothelial cells with inhibition of HA-VSMC human aortic smooth 
muscle cells. The difference in mean viability between the two cells was found to be highest 
at concentration of V10 (VEGF: 1ng/ml).  
Figure 91 contains graph illustrating the viability of cells with increasing amounts of 
heparin (1 to 1000 units/ml). As previously, MTT viability assay suggested that increasing 
amounts of heparin reduces viability of HAAE-1 and HA-VSMC cells, in comparison with 
regular media. Increasing concentrations of heparin typically reduced the viability of both 
cells. Specifically, viability of both cells were significantly higher at H1 (heparin: 1 unit/ml) 
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than H10 (heparin: 10 unit/ml), H100 (heparin: 100 unit/ml) and H1000 (heparin: 1000 
unit/ml). There was no significant difference for viability of cells between H10 and H100. 
However viability at H10 and H100 was significantly higher than H1000, for both cell-types. 
When comparing the two cell-types, the viability of HAAE-1 was significantly higher than 
that of HA-VSMC at H1, H10 and H100 concentrations. There was no significant difference 
in viability between the two cell types at H1000. As previously, these results also suggested 
heparin-induced selective proliferation of HAAE-1 human aortic endothelial cells with 
inhibition of HA-VSMC human aortic smooth muscle cells. The difference in mean viability 
between the two cells was found to be highest at concentration of H100 (heparin: 100 
units/ml).  
These findings were used to develop differential interfaces to allow controlled growth 
and proliferation of HAAE-1 with inhibition of HA-VASMC in microfabricated regions. 
VEGF concentration at 10 ng/ml and heparin at 100 units/ml were integrated with Matrigel® 
polymer matrix to allow development of scaffolds within the microfabricated rings/channels. 
Figure 92 contains MTT viability analysis of HA-VSMC and HAAE-1 in Matrigel® and 
Matrigel® with 10 ng/ml of VEGF and 100 units/ml of heparin normalized with media. 
Viability of HA-VSMC reduced significantly and viability of HAAE-1 increased 
significantly with addition of V10/H100 to Matrigel® matrix. Evidently, the viability between 
the cells was significantly larger with addition of V10/H100 to Matrigel®. Figure 93 contains 
optical micrographs of the two cell-types under V10/H100 conditions. These results 
confirmed earlier finding of VEGF- and heparin-induced proliferation of HAAE-1 human 
aortic endothelial cells with inhibition of HA-VSMC human aortic smooth muscle cells.  
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Figure 90. MTT cell viability of HA-VSMC and HAAE-1 for varying amounts of vascular 
endothelial growth factor (VEGF: 1-1000 ng/ml) normalized with media. Data represented 
as mean ± standard deviation. (p<0.05) 
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Figure 91. MTT cell viability of HA-VSMC and HAAE-1 for varying amounts of heparin 
(1-1000 units/ml) normalized with media. Data represented as mean ± standard deviation. 
(p<0.05) 
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Figure 92. MTT cell viability of HA-VSMC and HAAE-1 for Matrigel®, Matrigel® (with 10 
ng/ml VEGF and 100 units/ml heparin) normalized with media. Data represented as mean ± 
standard deviation. (p<0.05) 
 
 
Figure 93. Optical micrograph of A) HA-VSMC and B) HAAE-1 cells (in Matrigel + 10 
ng/ml VEGF + 100 units/ml heparin) at 24 hours post seeding. Scale bar equals 100 μm. 
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Matrigel® containing V10/H100 was used to promote proliferation of HAAE-1 
endothelial cells and inhibit growth of HA-VSMC smooth muscle cells in selective layers. 
HAAE-1 and HA-VSMC were seeded in microfabricated agarose channels and single-ring 
designs to observe growth and proliferation. The cells were then seeded on three-circular ring 
designs with human elastin in the centre layer. Figure 94 contains an optical micrograph of 
an elastin-stained agarose channel. The middle-ring layer containing HA587 human elastin 
was stained dark purple.  
As observed previously with with B35 neuroblast-like cells, within 6–9 h, the cells 
stayed well-adhered to the Matrigel® filled microfabricated regions and did not adhere to the 
remainder of the agarose area. The HAAE-1 human aortic endothelial cells and HA-VSMC 
human aortic smooth muscle cells showed signs of differentiation with distinctive change in 
morphology. Between 12-24 h, the cells continued to proliferate within the micromachined 
region with increased coverage. By 48 hours, the cells became confluent and past 72 hours 
they delaminated from the gel into a free-standing tissue-like network. Figure 95A contains 
an optical micrograph of HA-VSMC-Matrigel® network in a confluent state. These full 
grown cellular networks start to delaminate from the agarose gel interface at 72 hours. Figure 
95B contains an image of a 200μm partially delaminated HA-VSMC-Matrigel® network. The 
micromachined channel is clearly visible.  
The cells were also studied in co-culture (50:50 media) to develop vascular tissue-like 
networks. Figure 96A contains an optical micrograph of multi-layered HAAE-1/HA-VSMC-
humanelastin-Matrigel® network containing 10 ng/ml VEGF and 100 units/ml heparin. The 
entire network was delaminated without much change from the original design. Figure 96B 
contains live/dead stained image of a HAAE-1 network at 48 hours. Figure 97 contains 
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additional live/dead images of HA-VSMC network, HAAE-1 network, and multi-cellular 
networks. The multi-cellular network in Figure 97C was comprised of HA-VSMC/HAAE-1-
Matrigel®-human elastin network. The endothelial layer on the inner ring became confluent 
in a Matrigel®+10 ng/ml VEGF+100 units/ml heparin environment. Human elastin was 
present in the middle layer, and smooth muscle cells proliferated on the outer layer. Green 
fluorescing nuclei in these live-dead stained cells indicated viability of the cell with no 
damage to the nucleus. In some cases during co-culture, few red fluorescing dead cells 
indicating apoptosis were also observed. Live/dead analysis of the multi-cellular networks 
showed (>99%) viability at 72 hours without any loss in structural integrity. Post 72 hours all 
networks delaminated into a free-standing network. This aspect ratio was preserved after 
delamination and the free-standing multi-cellular structure was sustained in media for 96 
more hours. These results follow similar patterns to previously observed delamination with 
B35-neuroblast-like cell networks.      
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Figure 94. Optical micrograph of an elastin-stained agarose channel containing HA587 
human elastin in the middle layer. Scale bar equals 250 μm. 
 
 
 
Figure 95. A) Optical micrograph of a full-grown HA-VSMC-Matrigel® network at 72 
hours. Scale bar equals ~ 2 mm. B) Optical micrograph of a 200 μm delaminated HA-
VSMC-Matrigel® network, post 72 hours. Scale bar equals ~ 250 μm. 
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Figure 96. Optical micrograph of A) multi-layered HAAE-1/HA-VSMC-humanelastin- 
Matrigel® (V10/H100) network at 72 hours and B) live/dead stained HAAE-1 network at 48 
hours. Scale bar equals ~ 250 μm. 
 
 
Figure 97. Live/dead stained fluorescent micrographs of A) HA-VSMC-Matrigel® network, 
B) HAAE-1-Matrigel® network, and C) HA-VSMC/HAAE-1-Matrigel®-human elastin 
network.  Images were recorded at 48 hours. Scale bar equals ~ 200 μm. 
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Most conventional techniques have employed cell-seeding on a pre-formed polymeric 
conduit to facilitate growth of vascular networks, which may not entirely allow control over 
the various cellular and extracellular layers. CLM provides a unique direct-write approach to 
microfabricate complex geometries that may be used to develop vascular networks including 
small diameter blood vessels for bypass surgery and repair of heart components. Further, 
microscale integration and computer-aided controlled alignment of multi-cellular 
components may allow development of unique tissue-constructs for next-generation patient-
specific care.  
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3.4 PIT - Piezoelectric Ink-jet Technology 
Synthetic adhesives have largely displaced natural adhesives in the automotive, 
biomedical, and electronic equipment industries over the past century. However, rising 
concerns over the environmental and health effects of solvents, monomers, and additives 
used in synthetic adhesives have recently led the scientific community to seek natural 
alternatives. Marine mussel adhesive protein is a formaldehyde-free natural adhesive that 
demonstrates excellent adhesion to several classes of materials, including pure metals, metal 
oxides, polymers, and glasses.  
In this section, piezoelectric ink-jet technology was developed for CAD/CAM 
administration of naturally derived and synthetic biological adhesives. A MEMS based 
piezoelectric actuator was used to control the flow of the adhesive solution through the ink 
jet nozzles. Various characterization techniques were employed to determine the extent of 
chelation caused by Fe(III) on mussel proteins. Piezoelectric ink-jet printing of naturally 
derived biological adhesives may overcome several problems associated with conventional 
tissue bonding materials, and may be employed for future clinical applications.  
As a first step, PIT process was validated using biological proteins. Various aspects 
including feasibility of ink-jetting, resolution of the micropatterns, biological activity of 
proteins after processing, were analyzed. Similar steps were also taken for administration of 
adhesives.  
 
 
 
148 
3.4.1    Validation with Streptavidin/Biotin 
The piezoelectric print-head utilizes a voltage waveform input that allows control 
over volume of solution dispensed. The print head moves the ink solution from the cartridge 
to the channel. The impedance matching unit allows the solution to move through the 
descender where it is ejected through a 21 μm nozzle. Sixteen such nozzles are employed. 
 
3.4.1.1 Microscopy 
Figure 98 contains images of the streptavidin ink drops generated at 13 V using a 
high speed camera. Images a, b, c, and d were recorded at 20, 50, 100 and 200 μs time 
delays, respectively. At constant voltage and firing frequency, the drop traveled 
approximately 90 μm after 20 μs, 290 μm after 50 μs, 600 μm after 100 μs, and 1170 μm 
after 200 μs. The mass-velocity remained constant after the initial period of 25-30 μs. A 
graph showing drop travel at various time intervals is also shown. Figure 99 contains 
fluorescent micrographs of the streptavidin microarray. The streptavidin protein was labeled 
with rhodamine for detection using fluorescence microscopy. Distinct microscale protein 
structures with feature sizes of ~20 μm were observed. Owing to control over front-velocity 
of the droplet, piezoelectric ink-jet printing may allow proteins to be embedded into gel-like 
substrates. Figure 100 contains optical fluorescence micrographs of streptavidin microarrays 
embedded into a methylcellulose gel at various resolutions. The embedding depth was varied 
by changing the fluid velocity. Figure 101 contains a microarray pattern of fluorescein-
labeled biotin drops (~20 μm diameter) on a silicon substrate.  
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Figure 98. Optical micrograph of streptavidin drop generated at 13 V and captured at t=20, 
50, 100 and 200 μs, and corresponding graph of drop travel (microns) vs. time 
(microseconds). 
 
 
Figure 99. Fluorescent micrographs of rhodamine-labeled streptavidin microarray deposited 
on a silicon substrate. Shown at different magnifications. 
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Figure 100. Fluorescent micrographs of rhodamine-labeled streptavidin microarray patterned 
on a methyl cellulose gel (embedding matrix). Shown at different magnifications. 
 
 
Figure 101. Fluorescent micrograph of fluorescein- labeled biotin microarray deposited on a 
silicon substrate. Scale bar equals 50 μm. 
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3.4.1.2 Atomic Force Microscopy 
Figure 102 contains low and high resolution atomic force micrograph (topographic 
scan in contact mode) of the protein micropattern. Within the ink -jetted protein pattern, the 
microstructural arrangement appears to be randomly oriented. Three-dimensional 
topographic images are shown in Figure 103. The microstructures varied between 3 and 8 μm 
in length and were ~2 μm in height. These structures demonstrate spacing of 8-10 μm. Over 
a 0.67 mm scan size, the ink-jetted protein microstructures showed randomly oriented peaks 
and troughs, with distance (peak to peak) of 0.68 μm and average surface roughness of 
approximately 0.09 μm.  
 
3.4.1.3 Spectroscopy 
Fluorescence spectroscopy analysis for rhodamine-streptavidin and fluorescein-biotin 
demonstrate control over fluorescent signal output. This was achieved by an increase in 
deposited amount generated by increasing jetting voltages (10-40 V). Graphs are shown in 
Figure 104 and 105. Fourier-transform infrared absorption spectra overlay (Figure 106) of 
ink-jetted and drop-cast rhodamine-streptavidin demonstrate presence of relevant peaks 
(listed in Table 3). A strong match of all structurally relevant peaks suggested no damage to 
the protein during piezoelectric ink-jetting. These preliminary findings were used to validate 
the piezoelectric ink-jetting process for efficacy, accuracy, and repeatability, which were 
used in the next stages of developing this technology for next-generation bioadhesives.  
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Figure 102. Atomic force micrograph topographic scan of ink-jet-deposited rhodamine-
streptavidin micropattern at different resolutions. 
 
 
Figure 103. (Left): Three-dimensional topography of ink-jetted rhodamine-streptavidin 
micropatterns.   Scan size = 39 μm. Z-height = 5.29 μm. (Right): Height profile of the 
micropatterns. 
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Figure 104. Fluorescence spectroscopy reading for ink-jetted rhodamine-streptavidin at 
various jetting voltages. 
 
 
Figure 105. Fluorescence spectroscopy reading for ink-jetted fluorescein-biotin at various 
jetting voltages. 
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Figure 106. FTIR absorption spectra overlay of ink-jetted and drop-cast rhoadmine-
streptavidin. 
 
Table 3. FTIR absorption peaks of ink-jetted rhodamine-streptavidin. 
Notation Peak wavenumber (cm-1) Peak Assignment 
a  3476.0 Monosubstituted amide (O=C-NH) 
b  2923.3 Strong amino acid zwitterions (H3N+-CH-CO2-) 
C 2868.4 Secondary amine (CH2 – N) 
D 1734.8 C=O stretching 
E 1458.5 Aromatic ring stretching 
f  1350.1 Weak amino acid zwitterions 
g, h  1297.9, 1249.9 (Aryl – NH) 
i  1110.8 (CH2- NH-CH2) 
j  948.1 Conjugate Thiol 
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3.4.2    CAD/CAM Administration of Natural Bioadhesives 
Next-generation bioadhesives are currently being developed to preserve the 
advantages of conventional cyanoacrylate adhesives, while lowering the exposure hazards 
and illness-associated with these materials. Marine mussel adhesive protein is a 
formaldehyde-free natural adhesive that has gained great interest in the scientific 
community.181-185 In this section, piezoelectric ink-jet processing of natural mussel adhesive 
proteins and their chelation to Fe is studied. The results were analyzed with cyanoacrylate 
tissue adhesives as controls. 
Mussel protein solutions (containing 80% Mefp-1, 20% Mefp-2 and 0.16 mM DOPA) 
were ink-jetted using a validated waveform. Images of the drop dispensed at various voltages 
(Figure 107) was used to estimate the velocity and volume dispensed (in picoliters) for a 
given CAD pattern. A 2.5 V increase in jetting voltage developed a significant effect 
(p<0.05) over the jetting velocity. Figure 108 contains a graph of drop velocity (of protein 
solution) plotted against various jetting voltages. A linear increase in mean velocity with 
increasing voltages can be observed. Such control over picoliter amount of volume dispensed 
may allow developments in precision administration and tooling for next-generation surgical 
applications. 
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Figure 107. Optical micrograph of mussel protein solution ink-jetted at various voltages (15 
- 40V). Images were captured at 30 μs time-delay. 
 
 
Figure 108. Graphical representation of drop velocity of protein solution vs. jetting voltage. 
Values expressed as mean velocity ± standard deviation. (P<0.05) 
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3.4.2.1 Microscopy 
  Mussel protein solution, FeCl3 solutions and synthetic cyanoacrylate tissue adhesive 
resins were successfully deposited into CAD patterns. Ink-jetting of mussel protein solution 
in microarray patterns showed resolution up to 50 μm and in line-patterns showed 
approximate widths of 60 μm, 90 μm, 180 μm, and 300 μm (Figure 109). Ink-jetting of 
cyanoacrylate adhesives showed development of micropatterns with control over 2D space 
(Figure 110). An average human cell-size is approximately 20 μm. Thus, bonding line-widths 
of approximately 60 μm as demonstrated here may be sufficient for microsurgery and 
delicate wound-closure procedures. 
 
3.4.2.2 Contact Angle Measurements 
Contact angle study (Figure 111) performed on mussel protein solutions with varying 
Fe(III) content showed hydrophilic characteristic values (Table 4). Addition of FeCl3 to 
DOPA (in mussel protein solution) in ratios of 1:1, 10:1, and 100:1 showed no significant 
change in contact angle values (p<0.05).  
 
3.4.2.3 Spectroscopy 
Fourier-transform infra-red absorption (FTIR) spectra overlay of ink-jetted (at 
voltages 10, 20, 30 and 40 V) and drop-cast mussel protein solution (Mefp) (as control) 
revealed the presence of all relevant structural peaks (Figure 112A). However, an increasing 
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shift in absorption peaks was observed, which was consistent with increasing jetting voltage. 
This result may be attributed to the increase in jetting volume that results from an increase in 
voltage, as seen previously. FTIR spectra overlay of ink-jetted mussel protein solution (Mefp) 
and Mefp with varying concentrations of iron (in Fe:DOPA ratios of 1:1, 10:1, and 100:1) 
revealed match of all relevant structural peaks with no significant change in absorption 
intensity between the materials (Figure 112B). The FTIR spectroscopy data demonstrated 
that unlike thermal based prototyping systems, piezoelectric ink-jet printing does not 
significantly alter the structure (and thus the functionality) of mussel adhesive proteins 
(Mefp) and DOPA. Similarly, FTIR overlay of ink-jetted and drop-cast (control) n-butyl 
cyanoacrylate (Figure 113A) and 2-octyl cyanoacrylate (Figure 113B) revealed match of all 
relevant structural peaks, indicating no significant structural damage to the adhesive during 
piezoelectric ink jetting.  
X-ray photoelectron spectra of mussel protein solutions (Mefp) (Figure 114) revealed 
peaks C-C peak corresponding to 285 eV, C-N peak corresponding to 286.1 eV and N-C=O 
peak corresponding to 288.2 eV. The peaks may be attributed to aliphatic and aromatic 
carbons in the Mefp and DOPA group. Denconvolution of the C 1s peak revealed the 
percentage distribution of the peaks present (Table 5). Fe:DOPA in ratios 1:1 and 10:1 
revealed lower C-C than Mefp (0.16 mM DOPA) in the absence of Fe. However, excess 
amount of Fe(III) (as 100:1 Fe:DOPA) revealed increase in C-C peak and a decrease in N-
C=O peak. XPS spectra of ink-jetted protein solutions were inconclusive in determining the 
role of Fe(III) in complex formation. However, the distribution of peaks was similar to 
previously observed spectra in drop-cast mussel protein solutions.186 
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Figure 109. Optical micrographs of mussel protein (Mefp-1 and Mefp-2 containing 0.16 mM 
DOPA) solution ink-jetted into microarray and line patterns. Scale bar equals 100 μm. 
 
   
Figure 110. Optical micrographs of 2-octyl cyanoacrylate (Nexaband®) ink-jetted into 
microarrays. Scale bar equals 100 μm. 
 
 
 
 
 
 
160 
 
 
Figure 111. Contact angle measurement of an Mefp solution containing 80% Mefp-1, 20% 
Mefp-2 and 0.16 mM DOPA. 
 
Table 4. Contact angle measurements for mussel protein solutions with varying Fe content 
tested on Si (111) substrate. 
Solution on Si (111) substrate Contact Angle* 
Mefp (0.16 mM DOPA) 20.0° ± 2.2° 
1:1 Fe:DOPA 18.6° ± 2.0° 
10:1 Fe:DOPA 21.3° ± 1.6° 
100:1 Fe:DOPA 22.2° ± 1.9° 
Control: Deionized water 13.2° ± 1.6° 
*Values are expressed as mean + SD 
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Figure 112. (A) FTIR spectroscopy overlay of ink-jetted mussel protein solution (Mefp) as a 
function of jetting voltage (10-40 V). Control is a drop-cast mussel protein solution. (B) 
FTIR spectroscopy overlay of ink-jetted mussel protein solution (Mefp) as a function of 
Fe(III) concentration. Relevant structural peaks are labeled. 
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Figure 113. (A) FTIR spectroscopy overlay of ink-jetted and drop-cast (control) n-butyl 
cyanoacrylate (Vetbond®). (B) FTIR spectroscopy overlay of ink-jetted and drop-cast 
(control) 2-octyl cyanoacrylate (Nexaband®). Relevant structural peaks are labeled. 
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Figure 114. C 1s spectra of ink-jetted mussel protein solutions cured with varying amounts 
of Fe(III). X-ray photoelectron spectra shown for A) Mefp (0.16 mM DOPA), B) 1:1 
Fe:DOPA, C) 10:1 Fe:DOPA, and D) 100:1 Fe: DOPA. 
 
Table 5. Deconvolution of C1s peak from x-ray photoelectron spectra. 
Assignment C-C [a] C-N [b] N-C=O [c] 
Mefp (0.16 mM DOPA) 46% 35% 19% 
1:1 Fe:DOPA 44 38 18 
10:1 Fe:DOPA 42 37 21 
100:1 Fe:DOPA 50 36 14 
 
[a] C-C peak corresponds to 285 eV, [b] C-N peak corresponds to 286.1 eV, and [c] N-C=O 
peak corresponds to 288.2 eV 
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3.4.2.4 Atomic Force Microscopy 
Atomic force microscopy of ink-jetted mussel protein solution (Figure 115) revealed 
varying levels of precipitation/cross-linking upon addition of Fe(III). In the absence of Fe, 
mussel protein (Mefp) (Figure 115A) showed some cross-linking and presence of fibrous 
networks. The precipitation of long protein complex fibers was clear in 1:1 and 10:1 
Fe:DOPA (Figures 115B and 115C), with a higher degree of precipitation in 10:1 Fe:DOPA. 
Three-dimensional SPM imaging (Figure 116) at the surface of 1:1 Fe:DOPA revealed high-
aspect ratio fibrous structures, indicative of protein cross-linking. The height of these fibrous 
networks varied from approximately 400 nm to 800 nm, while the width varied from 500 nm 
to 5 μm. Excess amount of Fe in 100:1 Fe:DOPA revealed islands of cross-linked protein 
mass in most areas (Figure 115D). However, areas of fibrous networks within the printed 
pattern were also observed.  Binding properties of DOPA has been previously studied using 
atomic force microscopy measurements of DOPA residues against organic and inorganic 
surfaces.187 The interaction and strength is known to vary depending on the substrate. 
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Figure 115. Atomic force micrographs of ink-jetted A) mussel protein (0.16 mM DOPA), B) 
1:1 Fe:DOPA, C) 10:1 Fe:DOPA, and D) 100:1 Fe:DOPA solutions.                                    
Scale bar equals 10 μm. 
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Figure 116. AFM three-dimensional representation of the surface of mussel protein solution 
+ Fe(III) as 1:1 Fe:DOPA. Scan recorded 24 hours after curing. 
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3.4.2.5 Adhesive Properties 
Adhesive characteristics of pure marine mussel extracts have been previously 
examined under different curing conditions.188, 189 Low-humidity and non-oxidative 
conditions have been shown to be critical in obtaining strong adhesion properties in these 
materials. Tensile testing of ink-jetted mussel proteins (0.16 mM DOPA) on full-thickness 
porcine skin revealed significantly lower values than cyanoacrylate adhesives (Figure 117). 
Ink-jetted n-butyl cyanoacrylate (Vetbond ®) and 2-octyl cyanoacrylate (Nexaband®) showed 
no significant difference in strength. Ink-jetted ethyl cyanoacrylate (Quick SetTM Loctite®) 
showed highest strength among tested adhesives. Addition of Fe(III) to Mefp (0.16 mM 
DOPA) in 1:1 Fe:DOPA showed improved strength of adhesion. 10:1 Fe:DOPA did not 
show a significant change in strength in comparison to 1:1 Fe:DOPA. However, 100:1 Fe: 
DOPA revealed lower strengths than 1:1 and 10:1 Fe:DOPA, and no significant change in 
comparison to Mefp (0.16 mM DOPA).  
The extremities observed in the absence and excess of Fe content, may be correlated 
to the extent of cross-linking and precipitation in these ink-jetted patterns. As examined 
earlier, metal mediated catechol complexation is thought to responsible for the adhesion of 
the mussel plaque to the interface. It is also contemplated that two different ferric catecholate 
complexes may be formed at low and high Fe:DOPA ratios.190 Previous EPR studies have 
confirmed iron-induced cross-linking in precursor proteins matching that of intact mussel 
plaques.191 From the AFM images, the large area of fibrous networks observed in 1:1 and 
10:1 Fe:DOPA are not immediately evident in Mefp (0.16 mM DOPA) and 100:1 Fe:DOPA. 
This observation may be directly correlated with the adhesion strength observed in these 
materials. 
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Figure 117. Comparison of mean strength of bioadhesives ink-jetted on full thickness 
porcine skin. Bioadhesives: Mussel protein (0.16 mM DOPA), mussel protein (DOPA with 
increasing Fe content), Vetbond®, Nexaband®, and Loctite®. All samples were cured for 24 
hours. The difference in strength was statistically significant for all except those indicated by 
“*”, “^”, and “#” (P<0.05). Bars indicate standard deviation of mean strengths. 
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3.4.2.6 HAAE-1 Endothelial Cytotoxicity  
Mussel adhesive proteins do not interact with components of the human immune 
system, and thus may be useful in medical and surgical applications.192-194 Mussel species are 
also known to be immunogenic to erythrocytes and mouse tumor cells.195 Hybid of mussel 
adhesive proteins and RGD peptides have been demonstrated for applications as cell or tissue 
bioadhesive.196 
Figure 118 contains graph illustrating the MTT viability of HAAE-1 vascular 
entothelial cells for various bioadhesives. The data was normalized with cell-viability in 
media as control. Comparison of the MTT viability showed significant differences between 
all bioadhesives tested (p < 0.05). Cell-takTM containing polyphenolic proteins derived from 
Mytilus edulis showed greatest HAAE-1 viability at approximately 12% more than control 
media. Nexaband® (2-octyl cyanoacrylate) showed 9% greater viability than control media. 
All other bioadhesives showed lower viability than control. Mytilus edulis mussel proteins 
(80% Mefp-1 and 20% Mefp-2) solvated in water with a DOPA concentration of 0.16 mM 
showed greater viability than Vetbond® (n-butyl cyanoacrylate) and Loctite® (ethyl 
cyanoacrylate). Addition of Fe(III) to the mussel protein-DOPA solution significantly 
lowered the relative viability of cells from approximately 73% to 30%. A comparison at 
ratios of 1:1 Fe:DOPA, 10:1 Fe:DOPA, and 100:1 Fe:DOPA, showed significant reduction in 
cytoviability with addition of Fe(III). Iron has previously been shown to induce increased 
cytotoxicity in endothelial cells.197 Iron-induced toxicity to vascular endothelial cells have 
also been reported with implications in various vascular diseases.198 Employment of other 
elements in metal-mediated chelation of mussel proteins may address elevated cytotoxicity. 
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Mussel adhesive proteins could serve as environmentally friendly alternatives to 
cyanoacrylate adhesives in biomedical, electronics and marine-equipment applications. 
Mytilus edulis foot proteins may overcome several problems associated with conventional 
tissue bonding materials, and greatly improve wound repair in next generation eye repair, 
fracture fixation, organ fixation, wound closure, tissue engineering, and drug delivery 
devices. 
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Figure 118. MTT cell viability of HAAE-1 vascular endothelial cells for various 
bioadhesives normalized with media. Data represented as mean ²  standard deviation. 
(p<0.05) 
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3.4.3    CAD/CAM Administration of Synthetic Adhesives 
As previously, a MEMS based piezoelectric actuator was controlled to jet uniform 
fluid flow of the adhesive solution through the ink jet nozzles. Piezoelectric ink jet deposition 
of biological adhesives may greatly improve wound repair in next generation eye repair, 
fracture fixation, organ fixation, and wound closure. 
Vetbond® and CoSeal® solutions were successfully deposited into CAD patterns using 
the piezoelectric ink-jet printer. Ink-jetting of CoSeal® was achieved in two steps. First, the 
PEG powder/sodium carbonate solution (part I) was ink-jetted into a predefined pattern. This 
was followed by ink-jetting of the second component (HCl solution, part II) into a 
subsequent layer of the matching pattern. The gelation of CoSeal® was almost immediate. 
CAD/CAM micropatterns of CoSeal® hydrogel were more difficult to reproduce owing to the 
rapid setting upon mixing the two components.  
 
3.4.3.1 Microscopy 
Ink-jetting of Vetbond® tissue adhesive in microarray patterns in Silicon (111) 
showed good reproducibility (Figure 119) as seen in the previous section with Nexaband®. 
Figure 120 contains various patterns of CoSeal® hydrogel ink-jetted using this two-
component layer-by-layer approach. Figure 100A contains a circular ring pattern and Figure 
120B contains dot patterns of the two-component hydrogel. Figures 120C and 120D contain 
ink-jetted thin-film and thick-film of the hydrogel, respectively. Scanning electron 
micrograph performed on these patterns show additional details of the hydrogel formation 
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after ink-jetting the two-components separately. Figure 121A shows a 100X SEM image of 
the cross-linked hydrogel pattern. The width of the circular pattern varies from 300 to 400 
μm with uneven shrinkage and swelling across the pattern. Figures 121B and 121C contain 
higher magnification micrographs that reveal randomly oriented cross-linked networks of the 
hydrogel components.  
 
3.4.3.2 Spectroscopy 
 Fourier-transform infra-red (FTIR) absorption spectra overlay of ink-jetted and drop-
cast CoSeal® PEG-powder solution (part I) of the two component system shows match of all 
relevant structural peaks (Figure 122A). FTIR overlay of ink-jetted and drop-cast CoSeal® 
solution (part II) also revealed match in all structural peaks and close similarity to the peaks 
in part I (Figure 122B). The structural peaks in the formation of hydrogel via ink-jetting and 
drop-casting was also compared (Figure 122C) and revealed presence of all relevant peaks. 
The spectra of the hydrogel when compared with that of Part I and II showed presence of 
additional and narrower/sharper peaks.  
 Figure 123 contains X-ray photoelectron spectra survey of ink-jetted CoSeal® 
components (part I and II) in Silicon (111). The spectra revealed presence of C, O, Si and Na 
for PEG-powder solution (part I) and presence of C, O, Si for the other solution (part II). The 
positions of the peak, full-width half-max (FWHM), area and atomic percentage for both 
components are listed in Table 6. Figure 124 contains the C 1s spectra of the two 
components. The C-N peak corresponds to 286.1 eV shown in the curve-fitted graph.   
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Figure 119. Optical micrographs of n-butyl cyanoacrylate (Vetbond®) ink-jetted into CAD 
patterns. Scale bar equals 100 μm. 
 
 
Figure 120. Optical micrograph of CoSeal® patterns ink-jetted on borosilicate glass 
substrates. A: Circular ring pattern; B: Dot patterns; C: Thin-film; and D: Thick-film 
patterns. Scale bar equals 200 μm. 
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Figure 121. Scanning electron micrographs of CoSeal® circular ring pattern ink-jetted on Si  
(111) substrates. A: 100X, B: 1000X, and C: 10000X. 
 
 
Figure 122. Fourier-transform infra-red (FTIR) absorption spectra overlay of ink-jetted and 
drop-cast CoSeal® solutions. A. Part I (PEG-powder solution), B. Part II (HCl solution), and 
C. Part I+II (CoSeal® hydrogel formed by mixing the two-components). 
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Figure 123. X-ray photoelectron spectra survey of ink-jetted CoSeal® components. A. Part I 
(PEG-powder solution) and B. Part II (HCl solution). 
 
 
Figure 124. X-ray photoelectron C 1s spectra of ink-jetted CoSeal® components. A. Part I 
(PEG-powder solution) and B. Part II (HCl solution). 
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Table 6. X-ray photoelectron spectra survey of ink-jetted CoSeal® components. 
 Name Position FWHM Area At% 
O 1s 531.5 2.69 95266.20 35.00 
C 1s 285.5 3.16 43788.10 45.85 
Si 2p 97.0 1.91 15345.70 18.58 
CoSeal® PEG-
powder solution 
(Part I) 
Na 1s 1071.5 2.13 4302.20 0.56 
 
O 1s 532.0 2.21 86159.80 31.18 
C 1s 285.5 3.18 55630.50 57.38 
CoSeal®  
component in HCl 
solution (Part II) 
Si 2p 101.5 2.09 9584.80 11.43 
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3.4.3.3 Atomic Force Microscopy 
Figure 125 contains atomic force micrographs (deflection, topography and LFM) of 
CoSeal® hydrogel ink-jetted with pattern size of approximately 40 μm. The micrograph also 
revealed several rounded cross-linked networks of the hydrogel. A three-dimensional 
representation of the topography micrograph (Figure 126) revealed a dome-shaped pattern 
with approximate peak-height of the hydrogel at 5.50 μm.  
Figure 127 contains atomic force micrographs of CoSeal® hydrogel ink-jetted into a 
thin-film. The micrographs revealed 1-6 μm round-shaped interconnected islands with an 
uneven topology. The average surface roughness (Sa) over the 20 μm scan-range was 
observed to be 0.258 μm with root mean square (Sq) of 0.345 μm. Figure 128 contains 
atomic force micrographs of Vetbond® adhesive ink-jetted into a thin-film. The micrographs 
revealed presence of randomly oriented 2-3 μm globular structures. The size distribution of 
the features was narrower than that observed in the CoSeal® hydrogel. The average surface 
roughness (Sa) over the 20 μm scan-range was observed to be 0.117 μm with root mean 
square (Sq) of 0.180 μm, both lower than that observed in CoSeal® hydrogel. Figure 128 
contains atomic force micrographs of Loctite® quick set adhesive drop-cast into a thin-film. 
The micrographs revealed a smooth surface and an even topology. The average surface 
roughness (Sa) over the 20 μm scan-range was observed to be 0.034 μm with root mean 
square (Sq) of 0.045 μm, both significantly lower than that observed in the other two 
adhesives/sealants. 
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Figure 125. Atomic force micrographs of CoSeal® hydrogel ink-jetted in a dot-pattern. A: 
Deflection, B: Topography, and C: LFM. Scale bar equals 10 μm. 
 
 
Figure 126. AFM three-dimensional topographical representation of the CoSeal® hydrogel 
dot-pattern. Scan-distance = 60.45 μm, z-distace = 5.50 μm. 
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Figure 127. Atomic force micrographs of CoSeal® hydrogel ink-jetted into a uniform thin-
film on borosilicate glass substrate. A: Deflection, B: Topography, and C: LFM. Scale bar 
equals 5 μm. 
 
 
Figure 128. Atomic force micrographs of Vetbond® liquid adhesive ink-jetted into a uniform 
thin-film on borosilicate glass substrate. A: Deflection, B: Topography, and C: LFM. Scale 
bar equals 5 μm. 
 
 
Figure 129. Atomic force micrographs of Loctite® adhesive drop-cast on borosilicate glass 
substrate. A: Deflection, B: Topography, and C: LFM. Scale bar equals 5 μm. 
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3.4.3.4 Mechanical Properties 
 Figure 130 contains the measured average hardness of CoSeal® hydrogel, Vetbond®, 
and Loctite® polymer adhesive thin-films. The indentation depth was up to 500 nm for 
Vetbond® and Loctite®, and up to 750 nm for CoSeal® hydrogel. The average hardness values 
were highest for Loctite® followed by Vetbond® and lowest for CoSeal® hydrogel. The error 
bars in the charts signify the standard deviations of the data. Figure 131 contains the 
measured average modulus of the three adhesives under similar indentation depths. The 
average modulus followed a similar trend with highest values for Loctite® followed by 
Vetbond® and lowest for CoSeal® hydrogel. The difference in mean hardness and modulus 
values between all three adhesives were significantly different (p<0.01). Also, delamination 
of CoSeal® sealant from substrates after ink jetting, precluded adhesion strength 
measurements. The various measured properties of the ink-jetted cyanoacrylate adhsives and 
CoSeal® hydrogel are listed in table 7. 
Piezeolectric ink-jetting was revealed as a powerful, non-contact and non-destructive 
technique for controlled administration of surgical sealants and biological adhesives for 
future clinical applications. Microscopic patterning of adhesives/sealants including CoSeal® 
and Vetbond® enables improved bonding for a range of advanced biomedical applications. 
By printing such small and spatially aligned drops, bond lines between materials are reduced, 
ultimately resulting in increased bond strength and structural integrity. Unlike most other 
rapid prototyping techniques that employ heating elements or laser, piezoelectric ink-jetting 
is completely safe for biological adhesives.  
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Figure 130. Graph of hardness (GPa) vs. indentation depth (nm) of the adhesive thin-films. 
Symbols “” , “S”, and “y” represent values for Loctite®, Vetbond® and CoSeal® 
respectively. Bars indicate standard deviation of mean hardness. P<0.01 
 
 
Figure 131. Graph of modulus (GPa) vs. indentation depth (nm) of the adhesive thin-films. 
Symbols “” , “S”, and “y” represent values for Loctite®, Vetbond® and CoSeal®, 
respectively. Bars indicate standard deviation of mean modulus. P<0.01 
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Table 7. Measured properties of the adhesive thin-films 
Adhesive Formation/Components 
Average 
Hardness 
(GPa) 
Average 
Modulus 
(GPa) 
Average Surface 
Roughness, Sa 
(μm) 
CoSeal® 
Hydrogel formed by 
mixing synthetic PEG 
powder solutions 
0.022 0.522 0.258 
Vetbond® 
Polymerization of N-butyl 
cyanoacrylate 
0.095 2.240 0.117 
Loctite® 
Polymerization of Ethyl 
cyanoacrylate 
0.210 5.033 0.034 
 
 
 
CHAPTER 4 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
An aging population with growing healthcare needs demands multifaceted tools for 
diagnosis and treatment of health conditions. In the near-future, drug-administration devices, 
implantable devices/sensors, enhanced prosthesis, artificial and unique functional tissue 
constructs will become increasingly significant. Conventional rapid prototyping techniques 
do not sufficiently take individual patient anatomy into account and have several limitations 
that preclude their use for next-generation biomedical applications. Development of novel 
CAD/CAM rapid prototyping techniques may significantly accelerate progress of these 
devices for next-generation patient-care.   
In this dissertation, a variety of novel rapid prototyping methods were introduced and 
developed for several biomedical applications. First, two-photon polymerization (2PP) a laser 
direct write technique was studied for several photopolymers. Among them, Ormocer® 
photopolymer demonstrated superior mechanical strengths, surface properties and 
cytocompatibility. 2PP was used to microfabricate Lego®-like scaffolds for tissue 
engineering applications, microneedles for drug-delivery and ossicular replacement 
prostheses. A variety of microneedle geometries including off-centered tips were developed. 
Administration of fluorescing agents into skin demonstrated localized delivery within the 
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dermal layers. Polymeric microneedles developed by 2PP may be integrated with MEMS 
devices to allow control over amount and rate of pharmacologic administration. Ormocer® 
ossicular replacement prosthesis developed by 2PP demonstrated good mechanical 
properties, cytocompatibility, ease of forming and ease of handling. These results suggest 
that 2PP may be employed to create medical microdevices with a larger range of sizes, 
shapes, and materials than conventional polymer, silicon, stainless steel, or titanium 
microfabrication techniques. 
 Laser direct-writing may also be developed to create tissue constructs and scaffolds. 
CAD/CAM rapid prototyping by MAPLE direct write (MDW) allowed microfabrication of a 
variety of materials including bioceramics, organic polymeric materials, and viable cells such 
neuroblasts and osteoblasts. A triazene polymer release layer was developed to demonstrate 
lower threshold energy levels for micropatterning. Cytotoxicity studies showed no damage to 
cells during the process. The MDW process was also employed to develop microstructures of 
bioceramics such as hydroxyapatite, zirconia, and viable mammalian osteosarcoma cells. 
CAD/CAM co-deposition of osteosarcoma cells and hydroxyapatite may exploit advantage 
of osteoconductive properties of bioactive ceramics. Integration of viable cells and 
biomaterials prior to tissue fabrication may allow significant advantages including adequate 
cell penetration and control over cell-density through the scaffold.  Such a technique may 
allow integration of cell into the matrix while the construct is being created. 
MDW was demonstrated as a versatile technique for creating multilayer, 
heterogeneous structures that may be developed for tissue scaffolds. The ability to 
microfabricate cell-ceramic composites offers structural integrity in using two-dimensional 
layers to build mechanically robust three dimensional heterogeneous constructs. 
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Reproducible control over microstructure and surface characteristics may provide unique 
biological functionalities at the tissue/implant interface. The interaction among several MDW 
process parameters, including the laser fluence, laser spot size, ceramic powder size, ribbon-
substrate length, amount of solvent used to prepare the ribbon, and choice of solvent used to 
prepare the ribbon, may allow development of unique surface morphologies and improved 
tissue/implant interfaces. 
Every tissue and organ in the human body has its own unique geometry which varies 
in size between individuals undermines the applicability of most conventional fabrication 
techniques. Novel tissue engineering approaches are required to address issues facing 
conventional techniques and permit development of three-dimensional networks to replace 
failed tissue.  
In another laser-based approach, CAD/CAM laser micromachining (CLM) was 
developed to engineer biointerfaces with programmed dimensions and required functionality. 
CLM processing of silicon was used to understand laser interaction of material and to 
integrate the various process parameters. Microstructures and biointerfaces developed by 
CLM were utilized as surface recognition regions for differential adherence of cells to grow 
into tissue-like networks. The alignment and packing of cells within the microfabricated 
channels was dependent on the shape, growth rate, and signaling of cell. CAD/CAM 
generated free-standing self-sustained cellular networks of B35 rat neuroblast-like cells, 
A431 human epithelial carcinoma cells and C2C12 mouse myoblast-like cells were 
developed. Neuron bundles that match with the served nerve stumps may potentially aid in 
the regeneration of damaged peripheral nerves. Development of multi-cellular tissue 
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networks using selective growth factors may prove to be further valuable to the field of 
regenerative medicine. 
CLM was also developed for engineering multi-cellular vascular networks. Cytotoxic 
evaluations and growth studies demonstrated VEGF-induced proliferation of HAAE-1 
human aortic endothelial cells with inhibition of HA-VSMC human aortic smooth muscle 
cells. VEGF concentration at 10 ng/ml and heparin at 100 units/mL were integrated with 
Matrigel® polymer matrix to allow development of scaffolds within the CLM 
microfabricated networks. Conventional techniques for vascular networks have employed 
cell-seeding on a pre-formed polymeric conduits. Such techniques may not entirely allow 
control over cellular penetration and geometry of the various layers. CLM provides a unique 
direct-write approach to microfabricate complex geometries that may be used for vascular 
tissue engineering including small diameter blood vessels for bypass surgery and repair of 
heart components.  
Finally, a CAD/CAM liquid dispensing technique was developed to allow high-
throughput production of patterned multiplexed biological materials without the use of 
masks, stamps, ribbons, or other expensive processing equipment. Piezoelectric inkjet 
technology (PIT) was developed for controlled administration of naturally derived and 
synthetic biological adhesives. The PIT process was validated for feasibility, resolution, and 
safety using biological proteins. A MEMS based piezoelectric actuator was used to control 
the flow of solutions through the ink jet nozzles. Microscopic patterning of 
adhesives/sealants enables significant reduction of bond lines between materials, ultimately 
resulting in increased bond strength and structural integrity. PIT was demonstrated as a 
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powerful, non-contact and non-destructive technique for controlled administration of surgical 
sealants and biological adhesives. 
Various characterization techniques were employed to understand the role of metals 
such as Fe(III) on the adhesive properties of mussel proteins. Metal-mediated catechol 
complexation was thought to be responsible for the adhesion of the mussel plaque to the 
interface. Piezoelectric inkjet printing of naturally derived biological adhesives may 
overcome several problems associated with conventional tissue bonding materials, and 
greatly improve wound repair in next generation eye repair, fracture fixation, organ fixation, 
wound closure, tissue engineering, and drug delivery devices.  
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